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ABSTRACT

Complex I (E.C. 1.6.99.3) of the bacterium Escherichia coli is considered to be
the minimal form of the type-I NADH dehydrogenase, the first enzyme complex in the
respiratory chain. Because of its small size and relative simplicity, the E. coli enzyme has
become a model in the endeavor to identify and characterize the mechanism(s) by which
cells regulate the synthesis and assembly of this large respiratory complex.
To begin dissecting the processes by which E. coli cells regulate the expression of

nuo and the assembly of complex I, we undertook a genetic analysis of the fourteen
structural gene locus nuo that encodes the fourteen Nuo subunits comprising E. coli
complex I. We performed studies on an coisogenic collection of nuo mutants that focus
on the physiological, biochemical, and molecular consequences caused by the lack of or
defects in several Nuo subunits. Our findings provide insight into the regulation of nuo
expression and complex I assembly. In particular, we acquired evidence that the
peripheral subunit, NuoG, is essential for complex I function and that it plays a role in the
regulation of nuo expression and/or the assembly of complex I. Furthermore, we
demonstrated that Nuo subunits within the membrane arm of complex I may have dual
functions, working in conjunction with NuoG to coordinate transcription at the nuo
promoter thus providing a feedback mechanism of regulation. And, finally, we

xm

uncovered a seemingly complicated scheme of multiple sigma factor interaction at the
nuo promoter.
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CHAPTER!
INTRODUCTION

Regulation of Synthesis and Assembly of Multisubunit Complexes
The ability of a prokaryotic cell to tightly coordinate the synthesis and assembly
of large multisubunit complexes is crucial to its ability to react in response to its
environment (both internal and external) and to maintain efficient energy utilization.
Cells have devised a number of mechanisms to accomplish such coordinated regulation.
Three multisubunit complexes whose regulation is well understood are the Escherichia

coli and Salmonella typhimurium flagellar apparatus (59, 70, 71), the Rhodobacter
capsulatus photosystem components (7), and ribosomes (84).
Flagellar gene expression is coupled through a system ofhierarchial operons in
which the flagellar genes are clustered. The expression of one operon is dependent upon
the product(s) produced by another through an alternative sigma factor and other
transcription factors (71). Negative regulation of the late operons is achieved in part
through the anti-sigma factor FlgM. FlgM binds to the product ofthefliA gene,

0

28

,

thus

preventing expression of 0 28-dependent operons (70, 71). However, when assembly of
the flagellar apparatus reaches the stage of morphogenesis at which flagellin proteins can
be exported from the cell (to form the flagellar filament) through the apparatus, FlgM is
also exported out of the cell into the medium thus lowering its intracellular concentration.

1

2

In turn,

0

28

is released and becomes free to function in transcription initiation (59, 70).

This mechanism serves as a "developmental checkpoint" that links the regulation of gene
expression and assembly.
Expression of the R. capsulatus photosystem components are also tightly
regulated (7). Expression of pigment biosynthesis genes is coupled to expression of the
structural genes through various operons that overlap one another, designated
"superoperons". This provides for a balanced synthesis of the light-harvesting and
photopigment components. Furthermore, the various operons are controlled by different
transcription factors including an aerobic repressor, a two-component regulatory system,
and possibly an unidentified alternative sigma factor.
Many of the mechanisms that regulate ribosome synthesis and assembly are in the
form of translation-dependent feedback inhibition (84). Certain freer-proteins can act as
feedback inhibitors of translation of their own mRNA thereby coupling the synthesis of rproteins with ribosome assembly. Other r-proteins can regulate the synthesis of multiple
r-proteins from a polycistronic mRNA molecule.
Complex I in E. coli is also a large, multisubunit complex whose synthesis and
assembly we hypothesize are likely to be regulated, perhaps by the very subunits that
comprise complex I. Like many other multisubunit complexes, the genes that encode for
complex I are clustered (38, 68). Since the genes that encode the subunits of complex I
are not organized into several operons but rather localized within a single locus (nuo), we
may focus on the concomitant regulation of the promoter proximal and promoter distal
genes rather than looking for a hierarchial scheme of regulation. In thinking about this
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possibility of regulation, we need to keep in mind that all of the subunits encoded by the

nuo genes are known to have structural and/or enzymatic functions. The stoichiometry
of"l" for each subunit of complex I (38, 68) suggests the presence ofregulatory
components which coordinately balance the synthesis of every subunit. Further evidence
for a regulatory scheme is that the nuo locus is expressed in response to a number of
environmental stimuli (12, 106).

E. coli complex I as a Model System
Researchers have begun to utilize complex I of E. coli, and that of its close
relative S. typhimurium, to identify and characterize the mechanism( s) by which cells i)
regulate the synthesis and assembly of this large respiratory complex (3, 12, 106), ii) to
investigate the diverse physiological consequences caused by defects in this enzyme (4,
16, 91, 126), and iii) to study the mechanism of electron and proton translocation (3 7,
110, 114). These studies provide insight into bacterial energy metabolism and
macromolecular complex synthesis and assembly. Moreover, because of its relatively
small size and simplicity, E. coli complex I provides an excellent model system to study
mitochondrial complex I. Ultimately, these efforts will contribute to the medical
community's understanding of the relationship between defects in complex I and the
processes that lead to aging and diseases such as Parkinson's disease.
To begin dissecting the processes by which E. coli cells regulate the expression of

nuo and the assembly of complex I, we undertook a genetic analysis of the nuo locus.
Here, we present the results of studies, performed on an isogenic collection of nuo

4

mutants, that focus on the physiological, biochemical, and molecular consequences
caused by the lack of or defects in several Nuo subunits. In particular, we present ·
evidence that NuoG, a peripheral subunit, is essential for complex I function and that it
plays a role in the regulation of nuo expression and/or the assembly of complex I. We
also present data consistent with a role for another subunit, the membrane subunit NuoA
(a membrane subunit), in the regulation of nuo expression. Finally, we provide data that
suggests multiple levels of sigma factor regulation at the nuo promoter.

Complex I, The Enzyme
Complex I (E.C. 1.6.99.3; NADH:ubiquinone oxidoreductase), a type-I NADH
dehydrogenase that couples the oxidation ofNADH-reducing equivalents to the
generation of a proton motive force, is the first enzyme complex of the respiratory chain
(2, 82, 109, 111, 116) (Fig. 1). It performs the reaction

where Q refers to ubiquinone and H\ and H\ refer to the protons taken up from the
negative side of the membrane and delivered to the positive side of the membrane,
respectively (40). Complex I and related proton-pumping NADH dehydrogenases have
been identified in a variety of eukaryotic organisms (111, 116 for review) as well as in
the a.-,

P-, y-, and o-subdivisions of eubacteria (64, 66, 114, 119).
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Fig. 1. Schematic of the E. coli aerobic respiratory chain. NADH reducing
equivalents from glycolysis and the TCA cycle enter the respiratory chain through
complex I, a type I NADH-dehydrogenase. Complex I couples the oxidation ofNADH to
the generation of a proton motive force. It passes the electrons from the oxidation step to
the quinone pool where they then are passed on to either of two terminal oxidases and
finally to oxygen. The proton motive force generated by complex I drives the formation
of ATP. NDH-11, a type II NADH-dehydrogenase also oxidizes NADH, but does not
generate a proton motive force.
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Escherichia coli NADH Dehydrogenases

The Escherichia coli complex I, considered the minimal form of the enzyme·,
consists of fourteen polypeptide subunits (38, 67, 68, 73, 114), instead of the 40-50
structural and accessory subunits associated with the homologous eukaryotic
mitochondrial enzyme (72, 111, 115, 116), and contains a numbers of prosthetic groups
(FMN and Fe-S centers) (38, 67, 68). The E.coli enzyme is encoded by the fourteen
gene locus, nuo (NADH:ybiquinone Qxidoreductase), located between 49.2 and 49.6 min
on the chromosome (16, 68). In addition, E. coli possesses a second, single polypeptide
NADH dehydrogenase (type-II), NDH-II, which also oxidizes NADH and contains a
FAD prosthetic group (61, 62). However, this process is not coupled to the generation of
a proton motive force (73). This second NADH dehydrogenase is encoded by the ndh
(NADH .dehydrogenase) gene located at 22 min on the chromosome (16, 124).

E. coli complex I and nuo Locus
E. coli complex I resembles eukaryotic complex I in many ways (37, 38, 68, 114):

it consists of subunits homologous to those found in all proton-translocating
NADH:ubiquinone oxidoreductases (complex I) studied thus far (Table 1); it is
comprised of a large number of subunits relative to the number that comprise other
respiratory enzymes; it contains FMN and Fe-S center prosthetic groups; it performs the
enzymatic reaction that does eukaryotic complex I; and it is sensitive to the a number of
the same inhibitors. Additionally, it possesses an L-shaped topography (33, 46) like its
Neurospora crassa homolog (58) and can be purified as three distinct fragments.
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Table 1. The Nuo subunits and their homologs. E.c. refers to Escherichia coli, S.t. to
Salmonella typhimurium, P.c. to Paracoccus denitrifzcans, T.t. to Thermus thermophilus,
B.t. to Bov taurus, and Ne. to Neurospora crassa. IP refers to iron-sulfur protein fraction,
FP to flavoprotein fraction. *, mitochondrial-encoded. The data for various proteins
comes from the following sources: E.coli and B. taurus proteins (114); S. typhimurium
proteins (3 and Genbank accession numbers L22504 and U2521); P. denitrifzcans (120);
T. thermopilus (122); R. capsulatus (26-28); N crassa (5, 33). The predicted functions
are based on data from a number of sources (37-40, 68).

TABLE 1. The Nuo subunits and their homologs
Predicted function or
cofactor binding

E. c.

s. t.

P. d.

T. t.

R. c.

B. t.

N. c.

NuoA

NuoA

NQO7

NQO7

NuoA

ND3*

ND3*

NuoB

NuoB

NQO6

NQO6

NuoB

PSST

NuoC

NuoC

NQO5

NQO5

NuoC

30 IP

Nuo31

NuoD

NuoD

NQ04

NQ04

NuoD

49 IP

Nuo49

NuoE

NuoE

NQO2

NQO2

NuoE

24FP

Nuo24

1 X [2Fe-2S]

NuoF

NuoF

NQOl

NQOl

NuoF

51 FP

Nuo51

NADH-binding; FMN;
1 X [4Fe-4S]

NuoG

NuoG

NQO3

NQO3

NuoG

75 IP

Nuo78

2 X [4Fe-4S];
1 X [2Fe-2S]

NuoH

NuoH

NQO8

NQO8

NuoH
(NdhA)

NDl*

NDl*

ubiquinone-binding

Nuol

Nuol

NQO9

NQO9

Nuol (Ndhl)

TYKY

NuoJ

NuoJ

NQOlO

NQOlO

NuoJ

ND6*

ND6*

NuoK

NuoK

NQOll

NQOll

NuoK

ND4L*

ND4L*

NuoL

NuoL

NQO12

NQO12

NuoL

ND5*

ND5*

proton translocation

NuoM

NuoM

NQO13

NQO13

NuoM

ND4*

ND4*

proton translocation

NuoN

NuoN

NQO14

NQO14

NuoN

ND2*

ND2*

proton translocation

1 X [4Fe-4S]

2 X [4Fe-4S]

\0

Whereas eukaryotic complex I can be dissected into a peripheral arm and a membrane
arm, the E. coli enzyme is comprised of three subcomplexes referred to as the peripheral,
connecting, and membrane fragments (67) (Fig. 2A).
The organization of nuo (38, 68, 114) (Fig. 2B) and related genes is conserved in
several other bacteria, including Salmonella typhimurium (3), Paracoccus denitrificans
(118), Rhodobacter capsulatus (27), and Thermus thermophilus (122). The 5' half of the

nuo locus contains a promoter (nuoP) located upstream of nuoA (3, 12, 114) and the
majority of genes that encode subunits homologous to the nuclear-encoded subunits of
eukaryotic complex I (38, 67, 68, 114). In contrast, the 3' half contains the majority of
the genes that encode subunits homologous to the mitochondrial-encoded subunits of
eukaryotic complex I (38, 67, 68, 114), as well as sequences resembling transcriptional
termination signals (114).
The subunit composition of the three fragments of E. coli complex I correlates
approximately with the organization of the fourteen structural genes, nuoA-nuoN (38, 68,
114) (Fig. 2A & B). Whereas the nuclear homologs NuoE, NuoF, and NuoG constitute
the peripheral fragment (also referred to as the NADH dehydrogenase fragment or NDF),
the nuclear homologs NuoB, NuoC, NuoD, and Nuol comprise the connecting fragment.
The mitochondrial homo logs NuoA, NuoH, NuoJ, NuoK, NuoL, NuoM, and NuoN
constitute the membrane fragment (67). Based on predictions from conserved sequence
motifs (38, 63, 68), complex I inhibitor studies (37), and evolutionary relationships (39,
40), the E. coli complex I subunits which bind substrates, harbor redox groups, and
participate in proton translocation have been identified putatively (Table 1). The
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peripheral fragment is believed to be the electron input site (38); the membrane fragment
contains the ubiquinone-binding site (38, 68) and is thought to be involved in proton
translocation (39, 40, 63).

Similarity of E. coli complex I subunits to other bacterial enzymes
The subunits of complex I resemble subunits found in other bacterial electron
transfer and proton transporting enzymes (30, 39, 40, 111). The electron transfer moiety
of complex I is related to three different bacterial enzymes. The first enzyme is a soluble
NAD+-reducing hydrogenase encoded by the hox locus in the chemolithotrophic
bacterium Alcaligenes eutrophus (90, 107). This enzyme is composed of four subunits: a
(encoded by hoxF),

p (encoded by hoxll), y (encoded by hoxU), and 6 (encoded by

hoxY). Whereas the P/6 dimer is splits H 2 (H2 ➔2H+), the y/6 dimer functions as an
NADH oxidoreductase (diaphorase; NAD+➔NADH). The a/y dimer also contains an
FMN prosthetic group and a number of Fe-S clusters. NuoE, NuoF, and NuoG share
some homology to the a and y subunits whereas NuoB and NuoD share homology with
the 6 and Psubunits (Table 2). The gene order of the hox locus is conserved with respect
to the corresponding nuo genes. The second enzyme is the hydrogenase 3 of E. coli
formate hydrogenlyase encoded by the hyc operon (11 ). This enzyme couples the
oxidation of formate

(formate➔CO2 )

to proton reduction (2H+➔H2). All of the Hye

subunits share homology with Nuo subunits: HycE is related to NuoC and NuoD; HycG
is related to NuoB, which also contains an Fe-S center; HycF, a ferrodoxin, is related to
Nuol, also possessing Fe-S centers; and the membrane proteins HycC and HycD,

12

Fig. 2. Schematic of the E. coli complex I and the nuo locus. Adapted with permission
from T. Friedrich (38, 67, 68, 114). (A) E. coli complex I is comprised of three distinct
fragments: the peripheral (light gray), connecting (white), and membrane (dark gray)
fragments. The peripheral fragment (NDF) is comprised of the nuclear homologs NuoE,
F, and G and exhibits NADH dehydrogenase activity that oxidizes NADH to NAD+; the
connecting fragment is comprised of the nuclear homologs NuoB, C, D, and I; and the
membrane fragment is comprised of the mitochondrial homologs NuoA, H, and J-N and
catalyzes ubiquinone (Q) to its reduced form (QH2). (B) The E. coli nuo locus encodes
the fourteen Nuo subunits that constitute complex I. The 5' half of the locus contains a
previously identified promoter (nuoP) and the majority of genes that encode the
peripheral and connecting subunits (light gray and white, respectively). The 3' half of the
locus contains the majority of the genes encoding the membrane subunits (dark gray).
The 3' end of nuoG encodes a C-terminal region (CTR) of the NuoG subunit (hatched).
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Table 2. E. coli complex I subunits and their homologs in other bacterial electron
transfer enzymes and transporters. N-term., N-terminus; C-term., C-terminus; PTS,
phosphotransferase systems. A. eutrophus, Alca/igenes eutrophus; R. meliloti, Rhizobium
meliloti. This table is reproduced with permission from T. Friedrich; references for each
relationship have been reviewed (30, 39, 40, 111 ).

TABLE 2. E. coli complex I subunits and their homologs in other bacterial electron transfer enzymes and transporters

E.coli
complex I
NuoE
NuoF

A. eutrophus
NAD+-reducing
hydrogenase

Bacterial
hydrogenases

HycG

small subunit

R. meliloti
K+/H+
antiporter

Bacillus C-125
Na+/H+
antiporter

Bacterial
PTS

PhaA

ORFl

sugar
permease

PhaD

ORF4

sugar
permease

(HoxF)

a C-term.
(HoxF)

y (HoxU)

NuoB

o (HoxY)

HycE N-term.

NuoC
~

(HoxH)

HycE C-term.

NuoH

HycD

Nuol

HycF

NuoL

HycC

NuoM

Bacterial
glucose
dehydrogenases

a N-term.

NuoG
N-term.

NuoD

E. coli formate
hydrogenlyase

large subunit
N-term.

VI
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thought to be involved in ubiquinone binding, are similar to NuoL and NuoH,
respectively {Table 2). In contrast to the hox genes, the hyc genes do not correspond to
the order of the nuo genes.
The third enzyme is bacterial glucose dehydrogenase (glucose:ubiquinone
oxidoreductases) (74). This family of enzymes catalyzes the oxidation of glucose to
gluconolactone while reducing ubiquinone

(Q➔ QH2 ).

They can be inhibited by a number

of compounds that also inhibit complex I by interfering with its interaction with
ubiquinone (36, 37). The N-terminus of each of these enzymes is homologous to NuoH
{Table 2).
The proton translocating moiety of complex I is related to at least two bacterial
enzymes, i.e. certain antiporters and phosphoenolpyruvate-dependent phosphotransferase
systems (PTS). The membrane intrinsic PhaA and PhaD subunits of the Rhizobium
melioti K+/H+ antiporter share homology with NuoL and NuoM, respectively; likewise, a

related Na+/H+ antiporter in Bacillus C-125 contains a protein encoded ORFl that shares
homology with NuoL {Table 2). The pore-forming sugar permeases of the bacterial PTS
(93) also display some homology to NuoL as well as NuoM {Table 2).

Evolution of E. coli complex I
A possible mechanism of evolution of large multisubunit assemblies is that the
assembly arose by the accretion of its various component activities. This type of modular
evolution has been described for the bacteriophage lambda and for ATP synthases (18,
92, 111-113). For the bacteriophage lambda, the genes that encode the head are clustered
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together and those that encode the tail are clustered together. It has been proposed that
lambda phages exchange these gene clusters and so evolution is thought to operate at the
level of the individual functional units, not at the level of the intact virus (18, 92). The
ATP synthases are comprised of two membrane-bound structural modules, the extrinsic
F 1 (the ATPase module) and the intrinsic F 0 (the proton channel module). The clustering
of the genes that encode for each module and a conservation of gene order in various
organisms support modular evolution for this enzyme complex as well (112, 113).
The nuo genes are also clustered and their arrangement is conserved (refer to the

"E. coli complex I and nuo Locus" section above). And, E. coli complex I is similar to a
number of other bacterial enzymes. These pieces of data are consistent with the
possibility that E. coli complex I has evolved by fusion of preexisting modules for
electron transfer and proton translocation (30, 35, 39, 40, 111, 116).
The E. coli complex I is believed to have evolved first from a hydrogenase
(NuoB, NuoD), a ferrodoxin (Nuol), a transport protein (NuoM), a protein possessing a
quinone reduction site (NuoH), and a protein of unknown function (NuoC). A triplication
event of NuoM created NuoN and NuoL within the complex. The enzyme that resulted
was a common ancestor of complex I and formate hydrogenlyase. It likely used H 2 as an
electron donor working through NuoB-D and Nuol, while NuoL-N functioned in proton
translocation, and NuoH served as the ubiquinone-binding site. A more sophisticated
H 2 ::quinone oxidoreductase evolved upon the acquisition ofNuoA, NuoJ, and NuoK
(whose functions are unknown). Later in evolution, this primitive enzyme complex
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acquired the NADH dehydrogenase component (NuoE, NuoF, NuoG) which resulted in
complex I, an NADH:ubiquinone oxidoreductase.

Assembly of complex I

In the fungus Neurospora crassa, cells assemble complete complex I en bloc from
two independently assembled subcomplexes. Once both subcomplexes (arms) are
formed, they assemble into a single enzyme complex at the mitochondrial matrix (31, 34,
81, 98, 108), presumably through the actions of accessory proteins (111). The peripheral
arm, comprised of only nuclear-encoded subunits, assembles independently of the
membrane arm in cells grown in the presence of chloramphenicol, an antibiotic that
inhibits mitochondrial protein synthesis (34). The membrane arm, comprised of both
nuclear- and mitochondrial-encoded subunits, also assembles independently by cells
grown under Mn+2-limiting conditions, a condition that prevents the synthesis of the
peripheral arm (98). Accumulation of either arm occurs even if a subunit from one arm
is genetically disrupted (25, 31, 41, 54, 57, 81, 100).
The similarity of complex I in E. coli to the N. crassa enzyme in terms of
evolution and subunit functionality suggests that the E. coli and N. crassa enzymes may
also share similar modes of assembly (38-40, 68). The organization of the nuo locus is
consistent with the hypothesis that E. coli complex I assembly also proceeds first by
constructing independently assembled subcomplexes (38, 68). Perhaps, throughout the
evolution of complex I, regulatory components of each protein assembly remained within
the nuo locus to coordinate regulation of its two halves, ensuring proper assembly of a
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complete and functional complex I. Since E. coli harbors all of its nuo components in a
single cellular compartment, the regulation of expression and assembly would, however,
differ between E. coli and eukaryotes.

Regulation of nuo by External Regulators
Many components of the respiratory chain are known to be extensively regulated
at the level of transcription. In response to various electron donors and electron
acceptors, global transcriptional regulators (FNR, NarL, and ArcA) coordinately regulate
the expression of the dehydrogenases and terminal reductases of the respiratory chains
(48, 60, 109).
An extensive examination of the effect of external regulators on nuo transcription
in E.coli was performed by Bongaerts et al. (12) and Tran et al. (106). The first study
examined the role of electron acceptors, electron donors, and global transcriptional
regulators on nuo transcriptional control, while the second study focused on nuo
expression during formate respiration. These researchers determined that the electron
acceptors 0 2 and nitrate induce nuo transcription via the regulators ArcA, NarL, FNR,
and IHF. In contrast, cAMP-CRP seemed not to be involved. ArcA acted as a strong
repressor during anoxic conditions. NarL acted as a strong activator under the anoxic
conditions in the presence of nitrate. The global regulators FNR and IHF behaved as
weak repressors, exerting little effect on nuo transcription under anaerobic conditions.
This pattern of expression differs from that of ndh; ndh is primarily regulated by FNR
(44). Additionally, the electron acceptor fumarate (via an unknown mechanism) served
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to increase nuo expression anaerobically. In terms of electron donors, nuo transcription
was increased aerobically by C4 dicarboxylates (e.g. succinate, fumarate, and malate) and
acetate. Growth on substrates supplying high levels ofNADH, e.g. glucose or glycerol,
however, did not stimulate nuo expression either aerobically or anaerobically.
Furthermore, a comparison of operon and protein fusions demonstrated that the
expression of nuo is regulated at the level of transcription, not translation, by electron
donors and acceptors.
It is likely that E. coli possesses both its NADH dehydrogenases to effectively
maintain a redox balance in the cell (12, 16, 35, 52, 106) and to maximize energy
production/conservation (12, 16). nuo is expressed in the presence of many electron
donors and acceptors under both aerobic and anoxic conditions (12, 106), whereas ndh is
expressed primarily under aerobic conditions (44, 104). Both are repressed during
fermentation, when NADH cannot be reoxidized (12). It has been proposed that cells
may regulate the NADH/NAD+ levels in the cell and the amount of energy recovered
from NADH oxidation by controlling the relative levels and/or activities of the two
NADH dehydrogenases (16). Additionally, the presence of multiple NADH
dehydrogenases in E. coli, as well as other dehydrogenases, allows the cell to modulate
the electron flow through its respiratory chains in response to its environment (106, 109).

nuo promoter elements
Putative 0 70 -dependent -35/-10 sites were identified within the nuo promoter
region for E. coli (12, 114) and a -10 site was described in S. typhimurium (3). However,
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these sites were described as poor consensus sequences. Furthermore, in the study
performed by Bongaerts et al. (12), primer extension experiments revealed two
transcriptional start sites: one close to the start site described previously by Weidner et al.
(114) and a more distal site located at -173/-172. Additionally, two distinct regulatory
regions were defined. A proximal promoter region was shown to be required for
regulation by 0 2 and nitrate and the global regulators ArcA, NarL, and FNR, whereas a
distal promoter region was shown to be required for transcriptional stimulation by C4
carboxylates and acetate. These findings suggest that the nuo operon may possess more
than one promoter upstream of nuoA.

Defects in complex I
Defects in bacterial complex I cause pleiotropic phenotypes. In E. coli and/or S.

typhimurium, the defects affect the ability of cells to perform chemotaxis (91 ), to grow on
certain carbon sources (4, 8, 16, 91, 124), to survive stationary phase (126), to perform
energy-dependent proteolysis (4), to regulate the expression of the dnaN gene (75), and
maintain virulence (6). In Rhodobacter capsulatus, the defects prevent cells from
growing photosynthetically under anaerobiosis (28); while in Myxococcus xanthus, the
defects cause cells to halt the production of extracellular proteins and to fail to develop
and sporulate properly (66).
Defects in eukaryotic complex I also elicit severe physiological consequences. In
the fungi Neurospora crassa and Aspergillus niger, defects in complex I have been
shown to cause a number of defects, including a reduction in growth rate ( 1, 31, 54, 81,
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115) and poor conidiation (54). In humans, complex I defects are associated with
idiopathic Parkinson's disease, Leber's Hereditary Optic Neuropathy, and other severe
neuromuscular degenerative diseases (9, 13, 96, 99). These diseases predominately affect
brain and muscle, organs with the highest demand for ATP (116). Furthermore, complex
I deficiency has also been shown to play an important role in the aging process (21, 86,
89) and perhaps even in drug addiction (22). Since eukaryotic mitochondrial complex I
consists of 40-50 subunits, its size and complexity make it the least understood proton
translocating complex. This lack of understanding hampers efforts to define the role that
defects in complex I play in human disease.

CHAPTER II
MATERIALS AND EXPERIMENTAL METHODS

Chemical and Biological Reagents
Restriction enzymes were purchased from Promega Corporation (Madison, WI),
Gibco-BRL Life Technologies (Gaithersburg, MD), or New England BioLabs (Beverly,
MA). Antibiotics were purchased from Sigma Chemical Company (St. Louis, MO).
Enzymes and substrates were obtained from Boehringer Mannheim (Indianapolis, IN) or
Sigma Chemical Company. Radiolabeled materials were purchased from Amersham
(Arlington Heights, IL) and the bicinchoninic acid (BCA) protein assay reagent was
obtained from Pierce Biochemicals (Rockford, IL).

Bacterial Strains and Mutant Alleles
All strains are derivatives of E. coli K-12 and are listed in Table 3. The llnuoGJ
and nuoG2 mutant alleles were constructed by first subcloning a 7.0-kb EcoRI-PstI nuo
fragment from pAJW105/lPstI, a plasmid that encompasses the 3' end of nuoFto the 3'
end of nuoL (refer to Fig. 5), into the site-directed mutagenesis vector pALTER
(Promega Corporation, Madison, WI). Then, following the manufacturer's instructions,
two rounds of site-directed mutagenesis were performed using the primers CTRl
(5'-GTTTGGCAGCGATGAGTCGACACAGCGTGCTCCGG-3') and CTR2
23
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TABLE 3. Bacterial strains used in this study
Strain

Relevant genotype

Source
or reference

Wild-we:
CP366

po!A(Ts) thi-1 thr(am)-1 leuB6
hisF-4 rpsLJ 36a lac Yi xyl-5 aral 4
tonA31 tsx-78 rha zig::Tnl(l- Ace-

(50, 87)

CP875

thi-1 thr(am)-1 leuB6 hisF-4
rpsL13~ lacYJ A.lacX74 AlacY

(91)

K-12

prototrophic wild-type

ATCC #23716

AJW844

CP875 nuoB::Km

MCN021 X

CP875 ➔KmR Nuo-

AJW853

CP875 nuoB-C::Cmb

MWC230 X

CP875 ➔CmR

AJW851

CP875 nuoF::miniTnJ0Cmc

ZK1363 X

CP938

CP875 A.(nuoF-L)-1

(91)

CP910

CP875 nuoG::Tnl0-la

(91)

CP932

CP366 nuoG: :Tnl 0-1 a

(91)

AJW931

CP366 A.nuoGJd

This study

AJW1516

CP875 A.nuoGJd

This study

AJW1470

CP366 nuoG2e

This study

AJW1517

CP875 nuoG2e

This study

AJW845

CP875 nuoH::Km

NDl-KanR X

AJW846

CP875 nuol::Km

MCN091 X

AJW852

CP875 nuoM::miniTnlOCmc

ZK1362 X

AJW847

CP875 nuoN::Km

ANN141 X

AJW932

CP366 pHFl 7r integrate

This study

AJW1459

AJW931 pAJWl 05.6...Pstlg integrate

This study

AJW1472

AJW1470 pAJW105A...Pstlg integrate

This study

Nuo mutants:

Nuo-

CP875 ➔CmR Nuo-

CP875 ➔KmR Nuo-

CP875 ➔KmR

CP875 ➔ CmR

Nuo-

Nuo-

CP875 ➔KmR

Nuo-
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Strain

Relevant genotype

Source
or reference

AJW1567

CP875.1nuoG Jd
nuoM: :miniTnl 0Cmc

This study

AJW1568

CP875 .1nuoGJd nuoN::Km

This study

AJW1569

CP875 nuoG2e
nuoM: :miniTnl 0Cmc

This study

AJW1580

CP875 nuoB::Km
nuoF: :miniTnl 0Cmc

This study

AJW1581

CP875 nuoB: :Km nuoB-C: :Cmb

This study

AJW1582

CP875 .1nuoGJd nuoH::Km

This study

AJW1583

CP875 .1nuoGJd nuo/::Km

This study

AJW1584

CP875 nuoG? nuoH::K.m

This study

MCN021

nuoB::Km

(10)

MWC230

nuoB-C: :Cmb

R. Gennis

ZK1363

nuoF: :miniTnl 0Cmc

(126)

NDl-KanR

nuoH::Km

(10)

MCN091

nuol::Km

(10)

ZK1362

nuoM: :miniTnl 0Cmc

(126)

ANN141

nuoN::K.m

(10)

Sigma factor mutants:
UQ285

F- re/A+ stA+ argG lac thi [A cl857
h80 st68 dlac+] rpoD(Ts);
RpoD(o 70?s

(123)

AJW1015

CP875 rpoS(katF)::Km; RpoS(o s138}

ZKlO00 X CP875 ➔KmR

AJW1409

CP875 rpoN::TnJ0-P; RpoN(oN154}

YMC18 X CP875 ➔TcR

ZKlO00

rpoS(katF)::Km

R. Kolter
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Strain
YMC18

Relevant genotype

Source
or reference

rpoN: :Tnl 0-1 a

A. Ninfa

CP875 .dacsA::Km

S. Kumari

Others:
AJW803

nuoG::TnJ0-1 and zig::TnJO confer Tell; rpsLJ 36 confers Str8-.
The Cm cassette is located in the intergenic region between nuoB and nuoC.
c These mutations have been renamed to reflect their location within the nuo locus.
d The dnuoGI mutation is a 235-bp deletion of a 3' region of nuoG.
e The nuoG2 mutation is a 235-bp tandem duplication of a 3' region of nuoG.
rpHFl 7 confers ApR and carries the dnuoGJ allele.
gpAJW105APstI confers ApR and carries the wild-type nuoG allele.
a

b

(5'-GCGCGCATCTTGAGGTCGACAAGGAGGCACAACAA-3'), to create two
unique San sites flanking the 3' region of nuoG that encodes a C-terminal region (CTR)
of the NuoG subunit. Next, these sites were used for cloning purposes to construct one
plasmid (pHFl 7) that harbored a 235-bp deletion of the CTR (allele .dnuoGJ) and one
plasmid (pHF18) that harbored a 235-bp tandem duplication of the CTR (allele nuoG2).
HindIII fragments from pHF 17 and pHF 18 were subsequently subcloned into the

temperature-sensitive suicide vector pMAK.705 (52) to yield plasmids pHF68 and pHF69,
respectively. Finally, alleles .dnuoGI and nuoG2 were introduced into the chromosome
(Fig. 3) by means of homologous recombination following transformation with i)
plasmids pHFl 7 and pHF18, respectively, into the Nuo+ PolATs host strain CP366 (50,
87) or ii) plasmids pHF68 and pHF69, respectively, into the closely related Nuo+ strain
CP875 (52). Resultant recombinants were screened for the .dnuoGJ deletion or the
nuoG2 duplication by whole-cell PCR (94) using primers GI (5'-
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TTGGCGATCCGGGCGTGC-3') and Hl (5'-CAACCACCCAACCCGGAC-3') that
flank the nuoG CTR (Fig. 3). The wild-type nuoG allele produced a 717-bp product, the
ll.nuoGJ allele produced a 482-bp product, and the nuoG2 allele produced a 952-bp

product (Fig. 4). One CP366 ll.nuoG 1 recombinant (designated strain AJW931 ), one
CP366 nuoG2 recombinant (AJW1470), one CP875 ll.nuoGJ recombinant (AJW1516),
and one CP875 nuoG2 recombinant (AJW1517) were selected for further study. The nuo
mutant strains CP910 (allele nuoG::Tnl0-l) and CP938 (ll.(nuoF-L)-l) are derivatives of
the nuo wild-type strain CP875, while CP932 (nuoG::Tnl0-l) is a derivative of the wildtype strain CP366 (91). To add to this isogenic set of nuo mutants, generalized
transduction, using the phage Plkc (101), or transformation using chromosomal DNA
was used to transfer mutant nuo alleles from a variety of genetic backgrounds (10, 43,
126) into strain CP875. The location of the nuoB::Km mutation (strain AJW844) relative
to that of mutations nuoB-C::Cm and nuoF::miniTnl0Cm was verified genetically
(97.4% and 70.8% linkage, respectively) and confirmed by Southern blot analysis (data
not shown).
A strain carrying both the wild-type and ll.nuoG1 alleles on its chromosome was
isolated following an integrative, homologous recombination event by the Campbell-type
mechanism (88, 125) between pAJW105APstl, which carries the wild-type nuoG allele,
and the ll.nuoGJ po/A(Ts) strain AJW931 (Fig. 5). Following transformation and a shift
in temperature from 32 °C to 42 °C, a single, non-reciprocal, homologous recombination
event between the cloned insert in pAJWl 05APstI and the nuo locus in AJW931 resulted
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Fig. 3. Wild-type nuoG and mutant ll.nuoGJ and nuoG2 alleles. + 1, nuo transcription
initiation site (114). Restriction enzyme sites: E, EcoRI; P, Pstl; S, San derived by sitedirected mutagenesis to facilitate construction of mutant alleles. CTR (hatched), a 235-bp
3' region of nuoG present in the wild-type nuoG, deleted in the ll.nuoG1 allele, and
duplicated in tandem in the nuoG2 allele. Inverted triangle, location of the CTR deletion.
Gland Hl, flanking primers used to amplify CTR.
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Fig. 4. Products of PCR amplification to confirm the mutant anuoGJ and nuoG2
alleles. PCR was performed with plasmid or chromosomal DNA as described in
Materials and Experimental Methods using primers G 1 and Hl (see Fig. 3). The
products were electrophoresed on a 1.8% agarose gel containing 10 µg/ml EtBr.
Expected product sizes: wild-type nuoG allele, 717-bp; anuoGJ allele, 482-bp; nuoG2
allele, 952-bp. Markings on the left indicate the sizes of the <l>Xl 74 Haem DNA
marker (Gibco-BRL; marker sizes: 1350-bp, 1080-bp, 870-bp, 600-bp, 310-bp). Lanes
are as marked.
in a partial, non-tandem duplication of the nuo locus at either end of the vector sequence
(50, 87). The resultant strain was designated AJW1459. A similar strain (AJW932) was
constructed when the plasmid pHFl 7, which carries the mutant anuoGJ allele, was
integrated into the Nuo+ Po IATs strain CP366 in the same manner. Likewise, a strain
(AJW1472) carrying both the wild-type nuoG and mutant nuoG2 alleles on its
chromosome was constructed when the plasmid pAJWl 05LV>stl was integrated into the
nuoG2 polA(Ts) strain AJW1470. Maintenance of integration was verified following each

experiment by confirming the vector-encoded ampicillin resistance of each strain at 42 °C
(50) and the concurrent presence of both the wild-type nuoG and anuoGJ or nuoG2
alleles within the chromosome by PCR analysis using primers G 1 and Hl .
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Fig. 5. Construction of the cointegrate strain by integrational, homologous
recombination. Vector-derived nuo sequence (white); chromosome-derived nuo
sequence (gray); vector sequence (dotted line); ampicillin resistance, ApR. Other
designations as in Fig. 3 legend. The plasmid pAJW105Mstl encompasses the 3' end of
nuoFto the 3' end of nuoL and carries the wild-type nuoG allele. This plasmid was
transformed into competent AJW931 (llnuoGJ po/A(Ts)) cells. Cells in which the
plasmid had integrated into the chromosome by homologous recombination were
identified by selection for ampicillin resistance at the restrictive temperature, 42 °C. Not
shown: Strain AJW932 was constructed similarly, except that the plasmid pHFl 7, which
carries the llnuoGJ allele, was integrated into the Nuo+ PolATs strain CP366. Strain
AJW1472 was constructed in a similar manner by integrating pAJW105Mstl into strain
AJW1470 (nuoG2 po/A(Ts)). The concurrent presence of both the wild-type and mutant
nuoG alleles in each of these strains was verified by PCR analysis with primers G 1 and
Hl.
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Media and Growth Conditions
Cells were grown with aeration in tryptone broth (TB), composed of 1% (wt/vol)
tryptone and 0.5% (wt/vol) sodium chloride, or in Luria-Bertani media (LB), composed
of TB and 0.5% (wt/vol) yeast extract (78). When necessary, 100 µg/ml ampicillin, 15
µg/ml tetracycline, 34 µg/ml chloramphenicol, or 40 µg/ml kanamycin was added. Cells
were grown at 32 °C, unless otherwise stated. To obtain growth curves, cells were grown
in LB (supplemented with the appropriate antibiotics) to mid-exponential phase (0D 610
0.35-0.4), then diluted 10-2 into fresh TB (without antibiotics), and aerated until they
reached stationary phase. To obtain samples for p-galactosidase assays, cells were grown
the same as for growth curves and samples were removed at the indicated time points. To
test for the ability to use acetate as the sole carbon source, cells were grown in TB at
32 °C to mid-exponential phase prior to harvesting and resuspension at 10-5 (vol of 100
µl). 50 µl of the diluted culture was spread on M63 minimal media plates (91, 101)
supplemented with 25 mM sodium acetate (pH 7.0). Each plate was incubated at 32°C
for 55.5 h. When whole cell lysates were required, cells were harvested by centrifugation
at 3500 x g for 10 min at 4 °C, washed once with phosphate-buffered saline (PBS), and
lysed by sonication. 100 µl of the whole cell lysate was used to determine either the total
protein concentration of each sample by the BCA reagent method of Smith et al.1985,
using bovine serum albumin (BSA) as a standard (103) (Pierce, Rockford, IL), or to
perform P-galactosidase assays described below.
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Swarm Assays

Cells were aerated in TB supplemented with the appropriate antibiotics at 32·

0

c to

mid-exponential phase (OD 610=0.35-0.4). Tryptone swarm plates were 0.25% agar in the
same media. Antibiotics were not added. A 5 µl aliquot (10 6 to 107 cells) was inoculated
at the center of the surface of each swarm plate. Swarm plates were incubated at 32 °C in
a humid environment until the outermost, serine ring reached the edge of the petri plate
(117). The plates were then examined for the presence of the inner, aspartate ring (117).
The absence of this inner ring was taken as indicative of the Nuo- phenotype, i.e. the lack
of functional complex I (91 ).

Plasmid and Chromosomal DNA Preparation

Plasmid preparations were performed according to the alkaline lysis procedure
(95), using either the Promega Wizard Miniprep Purification System (Madison, WI) or
the QIAGEN plasmid midiprep kit (Santa Clarita, CA). Chromosomal DNA was
prepared as described (83) based on the principle of salting-out proteins. Cells grown in
3 ml LB were harvested, washed lX in PBS, resuspended in 1 ml SET buffer (75 mM
NaCl, 25 mM EDTA, 20 mM Tris-HCl [pH 7.5]), and lysed in the presence of 1 mg/ml
lysozyme. Preparations were incubated at 37°C for 0.5 h, and then incubated at 55°C for
1 h treated with 0.1 vol of 10% SDS and 1 mg/ml proteinase K. Cellular proteins were
precipitated by the addition of 0.33 vol of 5 M NaCl and 1 vol chloroform followed by
incubation for 30 min at RT on a rotating vertical wheel. The chromosomal DNA was
precipitated from the aqueous phase by the addition of 1 vol isopropanol followed by
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centrifugation at 3,200 x g for 5 min. The DNA was washed IX in 70% ethanol, dried,
and dissolved in dH2O. DNA concentrations, estimated by UV spectrophotometric
determinations, were calculated by the formula: concentration (mg/ml)= A 260/20.

Transformation of Competent E. coli
To make cells of E. coli strains competent, they were grown in 5 ml cultures of
YB media (2% Bacto-typtone, 0.5% Bacto-yeast extract, 0.5% MgSO4 , adjusted to pH
7.6 with KOH) at 37°C under aeration until OD 610=0.3. Cells were diluted 1:20 into fresh
prewarmed YB media grown under identical conditions until OD610=0.46, chilled for 5
min on ice, and centrifuged (5 min, 4 °C, at 3,200 x g). The supernatants were decanted,
cell pellets were resuspended in ice-cold Tbfl solution (30 mM potassium acetate, 100
mM KCl, 10 mM CaC12, 50 mM MnC12, and 15% [vol/vol] glycerol, adjusted to pH 5.8
with acetic acid), and chilled on ice for 5 min. Cells were again pelleted by
centrifugation, supernatants decanted, cell pellets resuspended in ice-cold Tbf2 (10 mM
MOPS, 75 mM CaC12 , 10 mM KCl, and 15% (vol/vol) glycerol, adjusted to pH 6.5 with
KOH), and chilled on ice for 15 min. Aliquots of frozen competent cells were stored at 70°C following freezing in an isopropanol/dry ice bath. Plasmid transformations with
competent cells were performed as described (53, 95, 101) by gently mixing a 50 µl
aliquot of thawed competent cells and 1-3 µl of plasmid DNA (1-10 ng) in a 15 ml roundbottom polypropylene tube. Contents were incubated on ice for 5 min, followed by a
heat-shock pulse at 42 °C for 60 s, and placed on ice for 2 min. LB supplemented with
0.25% glucose was added to transformed cells. These cells were allowed to express their
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respective antibiotic resistance( s) during a 1 h incubation before being plated onto
selective media and incubated ON. Chromosomal transformations were performed with
chromosomal DNA (~0.1 µg- 1.0 µg) from nuo mutant cells and transformed into
competent cells.

Generalized Transduction

Generalized transduction involved the use of P lkc (101 ). Donor phage lysates
were prepared by inoculating single colonies into 5 ml of LB and grown with aeration at
37°C ON. 50 µl of ON cultures were inoculated into two tubes containing fresh LB
media (5 ml, each supplemented with 0.2% D-glucose and 5 mM CaC12); to one tube no
phage was added (control); and to the other 100 µl of Pl phage lysate (grown on the
ATCC strain K-12) was added. Growth with aeration at 37°C continued until lysis was
complete. Lysates were clarified by the addition of 100 µl chloroform followed by
centrifugation at 3,000 x g for 15 min. Recipients cells were prepared by diluting ON
cultures into fresh LB media (supplemented with 0.1 % o-glucose and 10 mM CaC12) with
an initial OD610=0.02-0.04. These cultures were aerated at 37°C until they reached an
OD 610=0.4-0.6. Cells were then infected with 0, 10, or 100 µl donor lysate and incubated
without aeration for 20 min at 37°C. To prevent phage readsorption, 200 µl of 1 M
sodium citrate was added, the cells centrifuged, and the resultant pellets resuspended in
500 µl LB supplemented with 250 mM sodium citrate. The cells were then incubated at
37°C for 1 h to allow for expression, centrifuged, resuspended in 100 µl of lM sodium
citrate, and plated onto appropriate selection media. Transductions involving donor
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and/or recipient strains that carried the po/A(Ts) allele were grown at the permissive
temperature of32°C.

Cloning and Restriction Endonuclease Analysis
Restriction endonuclease digestions of chromosomal or plasmid DNA were
performed according to the manufacturers' specifications and as described (95). Digested
DNA fragments were electrophoretically separated on agarose gels 0.8%-2.0% (wt/vol) in
lX TAE buffer (40 mM Tris-acetate, 1 mM EDTA). Fragments< 500 bp were purified
with the Wizard PCR Prep Purification System (Promega); larger fragments were
purified by treating agarose pieces with 1.5 vol of 6 M NaCl followed by incubation at
50°C for 15 min, and purification of DNA with the Promega Wizard Miniprep
Purification System. Cohesive-end ligation of DNA fragments was performed as
described (95). Vector arms were usually dephosphorylated at 5' termini using calf
intestinal alkaline phosphatase (Gibco-BRL) according to manufacturer's instructions.

Polymerase Chain Reaction
Either plasmid DNA or chromosomal DNA was used as a template for the
polymerase chain reaction (PCR). To amplify products 200-bp to 1.2-kb in length, each
PCR, performed in a 100 µl volume, contained template (~ 10 ng plasmid DNA or ~ 100
ng chromosomal DNA), primers (0.1 m. each), deoxynucleoside triphosphates (0.2 mM
each), MgC12 (2.0 mM), PCR buffer (20 mM TrisHCl and 50 mM KCl), and 2.0 U Taq
DNA polymerase (Gibco-BRL). The PCR was performed in an Perkin-Elmer 9600
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Thermal Cycler (Foster City, CA) for 40 cycles. Each cycle consisted of denaturation at
94 °C for 30 sec, annealing for 1 min at 55 °C, and extension for 1 min at 72 °C. A final
5 min extension step at 72 °C was employed.
Long-distance PCR, using the Advantage KlenTaq Polymerase Mix (Clontech
Laboratories, Palo Alto, CA), was employed to amplify fragments > 1.2-kb. Each PCR,
performed in a 50 µ1 volume, contained ~ 100 ng chromosomal DNA as template, primers
(400 nM each), dNTPs (0.25 mM each), KlenTaq PCR reaction buffer [40 mM TricineKOH, pH9.2@25°C; 15 mM KOAc; 3.5 mM Mg(OAc)2; 75 µg/ml BSA; and IX
KlenTaq Polymerase Mix (KlenTaq-1 DNA polymerase, DeepVent DNA polymerase,
and TaqStart antibody (1.1 µg/µ1) in storage buffer)]. The PCR was carried out in a
Perkin-Elmer 9600 Thermal Cycler using the following profile: 1 cycle, 94 °C, 1 min; 30

., cycles, 95°C 15 s, 55°C 30 s, 68°C 6 min; 1 cycle, 68°C, 6 min; soak at 4°C .

RNA Extraction
Total cellular RNA was extracted from cells grown in TB at 32 °C to midexponential phase (OD 610=0.35-0.4) using the RNeasy mini prep kit columns according to
the manufacturer's instructions (QIAGEN). Prior to quantification, RNA samples were
subjected to DNasel (1 U/µg; RQl RNase-free DNasel; Promega) and purified using
RNeasy columns. The RNA concentration and purity were estimated by measuring the
A 260 and A 280 of the solution on a DU460 spectrophotometer (Beckman).
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Dot Blot and Northern Blot Analyses

For dot blot analysis, 0.5 µg RNA from each strain was directly transferred to
multiple GeneScreen Plus nitrocellulose membranes (NEN Life Science Products,
Boston, MA), using the Schleicher and Schuell (Keene, NH) dot blot apparatus according
to the manufacturers' instructions. The RNA was both heat- and UV-fixed to the
membranes. The resultant RNA dot blots were prehybridized at 42°C in the presence of
denatured, salmon or herring sperm DNA for 2-6 h in a buffer comprised of 5X SSC,
50% (w/v) deionized formamide, 5X Denhardt's solution, 1% SDS, and 10% dextran
sulfate (Na salt). Hybridization was performed for 16-28 h in the same buffer, except that
the nonhomologous DNA was excluded. DNA probes labeled with [a- 32P]dCTP using
the RTS RadPrime DNA labeling system (Gibco BRL) were added to the hybridization
solution following denaturing. The membranes were washed as per the manufacturer's
instructions before autoradiography with Kodak XAR film (New Haven, CT) at -70°C
for 8 days.
For northern blot analysis, 5 µg of total RNA was denatured at 65°C for 15 min in
the presence of 2M formaldehyde, 50% formaldehyde, and lX MOPS then
electrophoresed on a 1% agarose gel containing 2M formaldehyde and 50% formamide in
lX MOPS running buffer. 3 µl of 1 mg/ml EtBr was added directly to each RNA sample
prior to electrophoresis. Following electrophoresis, the RNA was transferred by capillary
action to a GeneScreen Plus nitrocellulose membrane (NEN Life Science Products) as
described by the manufacturer. The RNA was both heat- and UV-fixed to the membrane.
Prehybridization, hybridization, washing, probing, and autoradiography were all
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performed as described for the RNA dot blots. Stripping of the probe was performed by
boiling the membranes in a solution of 2% SDS and 2X SSC for 10 min. Stripping was
verified by autoradiography.

SDS-PAGE and Immunoblot Analysis
Total whole cell lysate protein (100 µg) and/or purified complex I (a gift from T.
Friedrich) were loaded onto 7 .5% polyacrylamide gels in the presence of 0.1 % SDS (65)
and subjected to a voltage of300 V, using a SE600 protein gel apparatus (Hoefer
Scientific Instruments, San Francisco, CA), until the loading dye was about 1 cm from
the bottom. The proteins were transferred electrophoretically overnight to 0.45 µm
nitrocellulose membranes using a Trans-Blot Cell apparatus (Bio-Rad Laboratories,
Richmond, CA). The membranes were blocked with 5% w/v nonfat dried milk in TBST,
composed of20 mM Tris-HCl (pH 7.6), 150 mM NaCl, and 0.1 % Tween 20, for 2 hat
room temperature. They were washed for 5 min in TBST before being subjected to
sequential incubation with rabbit anti-£. coli complex I polyclonal antibody #2409 (also a
gift from T. Friedrich) for 2 hat room temperature and goat anti-rabbit lgG (heavy and
light chain specific) alkaline phosphatase-conjugated antibody at appropriate dilutions for
2 hat room temperature. Finally, they were washed three times for 5 min each in TBST
between each incubation step. Color development was achieved with nitroblue
tetrazolium and 5-bromo-4-chloro-3-indoylphosphate as described (55).
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Fig. 6. Operon fusion vector. pHF9, a multi-copy nuoPA '::lacZYA transcriptional
(operon) reporter fusion constructed from pRS415 (102). The 443-bp nuo insert
consists of the nuo promoter (114) and the proximal third of nuoA. ApR, ampicillin
resistance; Tl 4, transcriptional terminator; trpA', trp operon sequence; lacZYA, lac
operon including its translational machinery but missing the lac promoter.

Reporter Fusion Construction and P-galactosidase assays

For studies examining the role of nuo mutations on nuo promoter activity, a multicopy nuoPA'::lacZYA reporter fusion was constructed by subcloning a 443-bp fragment
of plasmid pNUO2.3 (114) that encompasses the nuo promoter (nuoP) and the proximal
third of the nuoA gene into pRS415, an operon (transcriptional) fusion vector (102). The
resultant plasmid, pHF9 (Fig. 6), was transformed into both wild-type and nuo mutant
cells and the P-galactosidase activity of the transformants quantified as a measure of nuo
promoter activity (17, 102). P-galactosidase activity was determined in an ONPG assay
according to the procedure of Miller (78) and the Sigma Chemical Co. (St. Louis, MO),
except that the cells were disrupted by sonication, centrifuged at 12,000 rpm for 5 min,
and the initial rate of reaction was measured. The protein concentration was determined
by the BCA reagent method (103). p-galactosidase activity is expressed in terms of
specific activity (sp act; U/mg, where U=µmol ONP formed/min). Determination of both
protein concentration and p-galactosidase activity was performed using a DU640
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EcoRI
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EcoRI

Fig. 7. Protein fusion vectors. pHF13 and pHF14, multi-copy nuo::lacZYA
translational (protein) reporter fusions constructed from pRS414 (102). pHF13, the
short fusion, is analogous to pHF9 in that it contains a 443-bp nuo insert consisting of
the nuo promoter and the proximal third of nuoA. However, pHF14, the long fusion,
contains a 992-bp nuo insert consisting of the nuo promoter, the entire nuoA gene, and
the proximal third of nuoB. ApR, ampicillin resistance; T1 4, transcriptional
terminator; trpA ', trp operon sequence; lac 'ZYA, lac operon excluding its
transcriptional and translational machinery and the first seven codons of lacZ.

spectrophotometer (Beckman). For studies involving nuo::lacZYA protein (translational)
fusions, two multi-copy reporter constructs were made. These constructs differed from
pHF9, the operon fusion described previously. Both protein fusions lack the lac
translational machinery present in the operon fusion: instead they utilize nuo translational
machinery. One protein fusion, analogous to the operon fusion, was constructed by
subcloning a 443-bp fragment of plasmid pNUO2.3 (114) that encompasses the nuo
promoter (nuoP) and the proximal third of the nuoA gene into pRS414, a protein
(translational) fusion vector (102). The second fusion was constructed by subcloning a
larger 992-bp fragment ofpNUO2.3 that encompasses the nuo promoter (nuoP), all of the
nuoA gene, and the proximal third of the nuoB gene into pRS414. The resultant multi-
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copy fusions were designated pHF13 (the short fusion) and pHF14 (the long fusion),
respectively (Fig. 7).

Expression Constructs

The genes nuoH-Nwere amplified from the chromosome ofCP875 (wild-type) by
PCR using the high fidelity polymerase mixture Advantage KlenTaq Polymerase Mix
(Clontech Laboratories) and the primer G15 (5'-CACGCGTCTACATTAGTTACG-3'),
which lies 157-bp upstream of the nuoH start site, and primer N3
(5'-TAACGCTCTAGATCTATCTAC-3'), which lies 86-bp downstream ofnuoN. The
resultant amplification product was 7539-bp and contained unique Xbal sites flanking the
ends which were introduced by the primers. The Xbal sites were used to clone the
product into the expression vector pBAD33 (51) (Fig. 8). Since it is a pACYC184derived vector, pBAD33 is compatible with ColEl-derived vectors (such as pRS415, the
operon fusion vector). The cloning was not directional, therefore two constructs were
generated: one in which the nuo genes were oriented such that they would be transcribed
from the P 8 AD promoter and one in which the nuo genes were oriented opposite the P8 AD
promoter. These constructs were designated pHF78 and pHF79, respectively. Either
pBAD33 vector, pHF78, or pHF79 were transformed into wild-type cells (CP875) along
with pHF9 (the nuoPA '::/acZYA operon fusion). Single transformants and double
transformants were selected for by the appropriate antibiotic resistance(s) on LB plates
containing the chromogenic indicator X-gal (40 µg/ml) and L(+)-arabinose (0.05%) as an
inducer of PeAD· Subsequently, the transformants were grown in TB at 32°C in the
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pHF79
pHF78
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pBAD33

rrnRf12

Fig. 8. pBAD33:nuo expression constructs. pHF78 and pHF79, multi-copy
expression plasmids constructed from the pACYC184-derived, arabinose-inducible
vector, pBAD33 (50). araC, co-inducer of the ara operon; P 8 AD, the arabinoseinducible promoter of the ara operon; 5S and rrnBT 12 , parts of the 5S rRNA and the
strong rrnB terminators, respectively; bla', truncated P-lactamase gene; cat,
chloramphenicol acetyltransferase gene encoding Cm resistance. The 7539-bp nuoH-N
insert was cloned either in the same orientation as P 8 AD or in the opposite orientation
resulting in pHF78 and pHF79, respectively.

presence of antibiotics and 0.05% arabinose, until they reached mid-exponential phase
(OD 610=0.35-0.4). The p-galactosidase activity of these transformants was quantified in
an ONPG assay (described above) as a measure of nuo promoter activity (17, 102).

Computer Analysis
Protein sequence analysis was performed using the BestFit, Gap, Publish, and
PeptideSort programs within the Wisconsin Package software (version 8.1) of the Genetic
Computer Group (42). Protein sequence motifs were identified by searching the PROS/TE
Dictionary of Protein Sites and Patterns, also part of the Wisconsin Package. Autoradiographs
of the RNA dot blots, northern blots, and the photograph of the RNA agarose gel were scanned
using DeskScan II (56) and the images were compiled in PowerPoint (77).

CHAPTERIII
EXPERIMENTAL RESULTS

Polarity of nuo Mutants
To determine whether each nuo mutation exerts a polar effect upon transcription
of downstream genes, we performed RNA dot blot analysis. Additionally, this technique
allowed us to confirm the construction of each mutation beyond the restriction analysis,
Southern blotting, and/or PCR that had been used to first identify each mutation. From
cells carrying either the wild-type nuo locus (strains CP875 and CP366) or the mutant
alleles nuoB::Km (AJW844), nuoB-C::Cm (AJW853), nuoF::miniTnJOCm (AJW851),
A(nuoF-L)-1 (CP938), nuoG::TnJ0-1 (CP910), AnuoGJ (AJW931 and AJW1516),
nuoG2 (AJW1470 and AJW1517), nuoH::Km (AJW845), nuol::Km (AJW846),
nuoM::miniTnlOCm (AJW852), or nuoN::Km (AJW847), we purified total cellular RNA,

transferred that RNA directly to multiple nitrocellulose membranes, and then hybridized
each membrane with one of ten nuo probes (Fig. 9). Each probe hybridized to RNA
extracted from wild-type cells (lanes 1 and 2). Similarly, all probes complementary to
sequences located upstream of the reported location of each insertion hybridized to RNA
extracted from mutant cells. In contrast, probes complementary to sequences
downstream of each insertion hybridized poorly, if at all. For example, the upstream
probes nuoA, nuoB, nuo 'CDE ', nuoD, and nuoF, but not the downstream probes CTR,
45
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1 2 3 4 5 6 7 8 9 10

11

nuoA
nuoB
nuo'C,D,E'
nuoD
nuoF
nuoG

CTR
nuoH
nuol
nuo'M,N,3'
Fig. 9. Autoradiograph of RNA dot blots. Total RNA was purified from wild-type or
nuo mutant cells, 0.5 µg transferred directly to multiple nitrocellulose membranes, and
probed with the nuo genes or fragments indicated on the left. Lanes: 1, wild-type (strain
CP875); 2, wild-type (CP366); 3, nuoB::Km (AJW844); 4, nuoB-C::Cm (AJW853); 5,
nuoF::miniTnlOCm (AJW851); 6, il(nuoF-L)-1 (CP938); 7, nuoG::Tnl0-1 (CP910); 8,
ilnuoGJ (AJW931); 9, nuoH::Km (AJW845); 10, nuol::Km (AJW846); 11, nuoN::Km
(AJW847). The hybridization pattern for the nuoM::miniTnlOCm strain (AJW852) was
identical to that for the nuoN::Km strain (AJW847; lane 11); the hybridization pattern
for the ilnuoG1 strain AJWl 516 was identical to that of AJW93 l (lane 8). Every probe
hybridized to RNA from both nuoG2 strains, AJW1470 and AJW1517 (data not shown).
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nuoH, nuol and nuo 'MN3 ', hybridized with RNA from the nuoG: :Tnl 0- l strain (lane 7).
The faint signal observed with the nuoG probe likely resulted from its hybridization ·with
RNA encoded by the portion of nuoG located upstream of the insertion. We observed
similar hybridization patterns with RNA extracted from every nuo mutant constructed by
insertion (lanes 4, 5, 9, 10, and 11), with one exception: RNA from the nuoB::Km mutant
(lane 3) hybridized with the downstream probe nuo 'CDE'. The location of the
nuoB::Km mutation (strain AJW844) relative to that of mutations nuoB-C::Cm and
nuoF::miniTnlOCm was verified genetically (97.4% and 70.8% co-transformation
frequency, respectively) and confirmed by Southern blot analysis (data not shown).
Based on these two results, we conclude that the insertion does reside within the nuoB
open reading frame. The signal we observed with nuoB: :Km RNA when probed with the
nuo 'CDE' probe is not likely due to non-specific hybridization with any portion of nuoA
or nuoB; if that were the case, we would have expected a signal with every RNA.
Instead, it is possible that the signal is a result of contamination of the RNA. In contrast
to nuo mutants carrying insertions, those harboring the deletion alleles ll.(nuoF-L)-l (lane
6) or ll.nuoGJ (AJW931, lane 8) or those carrying the tandem duplication nuoG2
(AJW1470 and AJW1517, data not shown) exhibited different patterns. With these three
mutations, probes complementary to sequences both upstream and downstream of the
respective mutations hybridized. The CTR, nuoG, nuoH, and nuol probes did not
hybridize with RNA isolated from the ll.(nuoF-L)-l strain (lane 6), presumably because
those genes had been deleted from the chromosome. Likewise, the CTR probe did not
hybridize with RNA isolated from the ll.nuoGJ strain (AJW931, lane 8).
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On the basis of these observations, we conclude that each insertion used to
construct a nuo mutant exerted a polar effect upon downstream transcription. In contrast,
the two deletions and the tandem duplication each exerted no polar effect. Moreover, the
!1nuoGJ and nuoG2 alleles represent the only non-polar mutations constructed within a

single nuo gene.

Northern blot analysis
In an effort to examine individual nuo transcripts, we performed northern blot
analysis on total RNA isolated from either wild-type or !1(nuoF-L)-1 mutant cells. We
chose to examine the transcription of two genes, nuoA and nuoH. We anticipated that if
there were a single nuo transcript, then both probes would identify that transcript.
Likewise, if there were multiple nuo transcripts, then we may be able to identify some aor
all of them using these two probes. Additionally, by comparing the hybridization patterns
obtained with the nuoA probe versus the nuoH probe, we could determine whether the
signal we observed was specific or non-specific hybridization. Finally, we used the
unrelated acsA probe to serve as a positive hybridization control.
RNA was extracted from wild-type cells (CP875) at OD 610=0.25, 0.50, and 0. 75
and from !1(nuoF-L)-1 mutants cells (CP938) at OD 610=0.50. A photograph of the RNA
agarose gel following electrophoresis is shown in Fig. 10. Both the 16S and 23S rRNA
bands are clearly visible for each sample. The RNA was transferred to a nitrocellulose
membrane overnight by capillary action then heat- and UV-fixed to the membrane. The
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Fig. 10. RNA agarose gel. Cells were grown in TB at 32 °C to the indicated optical
density at which point total RNA was extracted as described in Materials and
Experimental Methods. 5 µg of total RNA from wild-type cells (CP875) and A(nuoF-L)1 mutant cells (CP938) was denatured at 65 °C for 15 min in the presence of2M
formaldehyde, 50% formaldehyde, and lX MOPS then electrophoresed on a 1% agarose
gel containing 2M formaldehyde and 50% formamide in lX MOPS running buffer. 3 µl
of 1 mg/ml EtBr was added directly to each RNA sample prior to electrophoresis. The
RNA marker sizes are indicated on the left (Gibco-BRL). The 23S (3.7-kb) and 16S
(1.7-kb) rRNA bands are indicated on the right. Not shown: A nuoA DNA fragment and
a nuoH DNA fragment were run on the gel to serve as positive hybridization controls
during northern blot analysis.
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membrane was probed with a nuoA probe, stripped, probed with a nuoH probe, stripped,
and probed with an acsA probe.
The nuoA probe hybridized in a diffuse pattern with RNA from both wild-type
and a(nuoF-L)-1 mutant cells (Fig. 1 lA). The signal appeared to center on the rRNA
bands and no signal was observed that exhibited slower mobility than the 23S rRNA
band. The nuoH probe also hybridized in a diffuse pattern centered around the rRNA
bands (Fig. 1 lB), but it did not hybridize to RNA extracted from the a(nuoF-L)-1
mutant. This is expected since the nuoH gene is deleted from the chromosome in this
mutant. The lack of a nuoHhybridization signal in the a(nuoF-L)-1 mutant indicates a
lack of non-specific hybridization with wild-type RNA. We observed that the
hybridization signal from RNA extracted from wild-type cells at OD610 =0.75 was less
intense than the signals from RNA extracted at OD 610 =0.25 or 0.5. Without an additional
loading control, we can not draw any conclusions about whether the difference in signal
intensities is significant.
To verify the integrity of total RNA, we probed the blot with an internal fragment
of the acsA gene that corresponded approximately in size to the nuoA probe (Fig. 1 lC).
A single transcript of about 2.1-kb was observed. This result had been obtained
previously (Kumari and Wolfe, manuscript in preparation). Furthermore, when we used

nuoA to probe a different blot (one that previously had displayed the acsA transcript; a
gift from S. Kumari), we again observed the diffuse hybridization pattern observed with
the first blot (Fig. 1 lD).
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Fig. 11. Autoradiographs of northern blots. RNA was transferred electrophoretically
from the agarose gel (Fig. 10) to a nitrocellulose membrane. The membranes were
stripped between each probing. Probes are indicated in the gray boxes. (A) nuoA
probed membrane, (B) nuoH probed membrane, (C) acsA probed membrane. The blots
in A-C were exposed to film for 8 days. (D) nuoA probed membrane; a different
membrane was used, one that had been probed previously with acsA and stripped. The
blot was exposed for 5 days. Wild-type, strain CP875; f:t.(nuoF-L) - 1, CP938.
dacsA::Km mutant, AJW803. 0D 610, the point at which the RNA was extracted from
the respective cells. The 23S and 16S rRNA bands are indicated to the right of each
blot.
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These results suggest that i) the hybridization signals we observed are specific for

nuo, ii) the hybridization pattern we observe with the nuoA and nuoH probes is a
phenomenon associated with nuo and is not due to non-specific hybridization, but iii) the

nuo transcript(s) does not appear to be stable under the conditions tested.

Phenotypes of nuo Mutants
To test whether i) the newly constructed llnuoGJ and nuoG2 mutants exhibited
the previously described Nuo- phenotypes and ii) all of the isogenic nuo mutants
exhibited the same phenotypes, we characterized the mutants by subjecting them to a
series of tests, each shown previously to distinguish wild-type cells from those of nuo
mutants (4, 8, 23, 24, 67, 68, 91). On the basis of the five phenotypic analyses, we
conclude that all of the nuo mutants tested exhibit a pleiotropic Nuo- phenotype.
Additionally, the data suggests that the nuoN mutant possesses a subassembled,
cytoplasmic peripheral fragment (NDF).
First, we inoculated cells carrying either the wild-type nuo locus (strain CP366) or
the mutant alleles nuoG::Tnl0-1 (CP932) or llnuoGJ (AJW931), at the center of TB
swarm plates, incubated those plates at 32°C until the outer, serine ring had reached the
edge, and examined them for the presence or absence of the inner, aspartate ring. Wildtype cells formed both rings (Fig. 12A). In contrast, the nuoG::TnJ0-1 mutant
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&iuoGJ
integrant

Fig. 12. Photographs of the swarms produced by the (A) wild-type strain (CP366), (B)
nuoG::TnlO-l mutant (CP932), (C) AnuoGJ mutant (AJW931), and (D) the AnuoGJ
integrant (AJW932), Cells were inoculated at the center of a TB swarm plate
containing 0.25% agar, and the plates incubated at 32 °C until the outer, serine ring
reached the edge of the swarm plate.

(Fig. 12B), the AnuoGJ mutant (Fig. 12C), and all other nuo mutants failed to form the
inner ring (Table 4).
Second, we inoculated TB with wild-type cells (strain CP875) or those that carry
the mutant alleles A(nuoF-L)-l (CP938), nuoG::TnlO-l (CP910), AnuoGJ (AJW1516),
or nuoG2 (AJW1517), aerated the cultures at 32°C, and monitored their growth as a
function of optical density (Fig. 13). Prior to mid-exponential phase, both wild-type and
mutant cells grew at similar rates. Whereas wild-type cells continued relatively rapid
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Fig. 13. Tryptone broth growth curve. Cells were grown in TB at 32°C. Growth was
monitored as a function of optical density versus time. The OD 610 of the wild-type strain
CP875 (■), the .d(nuoF-L)-1 strain CP938 (.d), the nuoG::Tnl0-1 strain CP910 (0), the
.dnuoGJ strain AJW1516 (v), and the nuoG2 strain AJW1517 (◊). The mean of six
independent experiments is plotted for each strain. The error bars represent ±SEM.
growth beyond OD610=0.3, mutant cells abruptly reduced their growth rate. Regardless of
genetic background, all other nuo mutants exhibited similar behavior (Table 4).
Third, to examine the cells growth on acetate as the sole carbon source, we
inoculated M63 minimal plates supplemented with 25 mM acetate or 0.25% glucose with
wild-type cells (strain CP875) and those carrying the mutant alleles nuoG::Tnl0-1
(CP910), .dnuoGJ (AJW1516), or nuoG2 (AJW1517), incubated those plates at 32°C for
55.5 h before photographing them. Relative to wild-type cells, mutant cells formed very
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small colonies on M63 acetate plates (~0.5 mm compared to ~ 1.0 mm for wild-type cells)
(Fig. 14). In contrast, all cells formed equally-sized colonies (~1.0 mm) on M63 glucose

wild-type

nuoG::TnlO

!1nuoGJ

nuoG2

Fig. 14. Growth on acetate. Photographs of colonies produced by the wild-type strain
CP875, the nuoG::Tnl0-1 strain CP910, the !:,,.nuoGJ strain AJW1516, and the nuoG2
strain AJW1517. Cells were inoculated on minimal media (M63) plates supplemented
with 25 mM sodium acetate (pH 7.0) and the plates were incubated at 32°C for 55.5 h.

plates. All other nuo mutants tested formed equivalent colony sizes (Table 4).

Fourth, complex I activity was examined in selected mutants by measuring the
NADH ferricyanide (FeCN) and d-NADH FeCN activities in their membrane fractions.
These experiments were performed by Thorsten Friedrich and colleagues at the HeinrichHeine-Universitat Diisseldorf. Whereas membrane fractions from wild-type cells
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exhibited both these complex I activities, membrane fractions of the mutant cells
exhibited much lower levels of these activities (10) (Table 4). The activities were not
completely abolished in the nuo mutants presumably because the second NADH
dehydrogenase, NDH-11, also reacts with both substrates (37).
Finally, using electron-paramagnetic resonance spectroscopy (EPR) analysis that
detects Fe-S centers of complex I in the membrane fraction of wild-type cells (67, 68,
114), Friedrich et al. tested for the presence of subcomplexes of complex I in the mutants.
The analysis revealed no detectable amounts of complex I or subcomplexes of complex I
in the membrane fractions or cytoplasm of any of the mutants tested with one notable
exception: EPR analysis detected Fe-S centers in the cytoplasm of the nuoN mutant, but
not in its membrane fraction (10) (Table 4). The presence ofFe-S centers in the
cytoplasm of nuoN mutants was confirmed by the purification of the peripheral fragment
(NDF) from those cells which was subsequently shown to resemble the NDF of purified
complex I in both enzyme activity and EPR spectroscopy (10).

Complementation of the ll.nuoGl and nuoG2 Alleles
We tested for complementation in cis (32) with multiple, independent isolates of
strains that carry both the wild-type nuoG and the mutant ll.nuoGJ alleles (strains
AJW932 and AJW1459) or that carry both the wild-type nuoG and the mutant nuoG2
alleles (AJWl 4 72) on their chromosomes by scoring each strain for their ability to
produce the inner ring in swarm assays (Fig. 12D; Table 4). Multiple, independent
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TABLE 4. Summary of Nuo Phenotypes
nuo
mutation

Strain

swarm
plate3

TB
growth
curveb

Growth
on

M63+
25mM
acetatec

NADH/
dNADH
FeCN
activityd

EPR
spectroscopy
analysise

CP875

w.t.

+

+

+

+

+

CP366

w.t.

+

+

NDr,g

+

+

AJW844

nuoB::K.m

-h

-h

AJW853

nuoB-C::Cm

NDr

NDr

AJW851

nuoF: :miniTnl OCm

-h

NDr

CP938

!l(nuoF-L)-l

CP910

nuoG::TnlO-l

CP932

nuoG::TnlO-l

NDr,g

NDr

NDr

AJW931

!lnuoGJ

NDr,g

AJW1516

!lnuoGJ

NDr

NDr

AJW1470

nuoG2

NDr

NDr

AJW1517

nuoG2

NDr

NDr

AJW845

nuoH::K.m

-h

-h

AJW846

nuol::K.m

-h

-h

AJW852

nuoM::miniTnl OCm

NDr

NDr

AJW847

nuoN::K.m

-h

+h

AJW932

CP366pHF17
integrant

+

+

NDr,g

NDr

NDr

AJW1459

AJW931
pAJWl 05!1Pstl
integrant

+

+

NDr,g

NDr

NDr

AJW1472

AJW1470
pAJWl05A.Pstl
integrant

+

+

NDr,g

NDr

NDr

AJW1567

!lnuoGJ
nuoM: :miniTnl OCm

NDr

NDr

AJW1568

!lnuoGJ nuoN::K.m

NDr

NDr

NDr,g
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Strain

a

nuo
mutation

swarm
plate•

TB
growth
curveb

Growth
on
M63+
25mM
acetatec

NADH/
dNADH
FeCN
activityd

EPR
spectroscopy
analysise

AJW1569

nuoG2
nuoM: :miniTnJ OCm

NDr

NDr

AJW1580

nuoB::Km
nuoF: :miniTnJ OCm

NDr

NDr

AJW1581

nuoB::Km
nuoB-C::Cm

NDr

NDr

AJW1582

t!nuoGJ nuoH::Km

NDr

NDr

AJW1583

t!nuoG 1 nuol: :Km

NDr

NDr

AJW1584

nuoG2 nuoH::Km

NDr

NDr

+, the presence of an inner, aspartate ring ; -, the absence of the inner ring.

+, no growth defect;-, growth defect.
+, good growth(~ 1.0 mm colonies);-, poor growth (5:0.5 mm colonies).
d +, presence of the activities in membrane fractions;-, decrease in these activities.
e +, the presence ofFe-S centers characteristic of complex I;-, lack of detectable Fe-S centers.
rND, not done for this study.
8 Strain background was Ace- prior to introduction of nuo mutation(s).
h Mutation analyzed in a different, but related, background.
b

c

isolates of each strain formed an inner, aspartate ring despite the fact that vector sequence
interrupts the partially duplicated nuo locus in these strains (see Fig. 5). Additionally,
strains AJW932, AJW1459, and AJW1472 did not exhibit the TB growth defect (Table
4). Since these strains exhibited these two Nuo+ phenotypes, we conclude that the
!::..nuoGJ and nuoG2 alleles can be complemented and that the mutant alleles are

recessive.
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Translational Analysis
We examined the ability of wild-type and nuo mutant cells to synthesize the
NuoCD and NuoG subunits (67), using a polyclonal antibody directed against purified
complex I (#2409). The NuoCD subunit has been identified as a single polypeptide (a
fusion protein) in E. coli (41 ). This finding is consistent with a study of the bacterium
Buchnera aphidicola which described a protein homologous to NuoC at its N-terminus
yet homologous to NuoD at its C-terminus (20). However, due to a sequence
discrepancy, it is not yet clear the mechanism for such a fusion protein. There is
possibility that the proposed nuoC stop TGA codon may code for the amino acid
selenocysteine or that the stop codon is simply out of frame and therefore only a single
nuoCD open reading frame exists.
We identified the bands that correspond to NuoCD and NuoG by comparing the
pattern of bands from purified complex I (67) (Fig. 15A and B, lane 1) to those of a
mixture of purified complex I and whole cell lysate from wild-type cells (strain CP366)
(Fig. 15A and B, lane 2) to whole cell lysates from wild-type cells alone, strains CP366
(Fig. 15A and B, lane 3) and CP875 (Fig. 15A only, lane 4). We examined both wildtype strains because the mutants were constructed in the two backgrounds. We failed to
detect NuoCD only in strains that carry an insertion mutation upstream of nuoC (Fig. 15A
only, lanes 5 and 6), but detected NuoCD in all other strains (Fig. 15A, lanes 3, 4, and 714; Fig. 15B, lanes 3-9). Similarly, we failed to detect NuoG in strains that either lack
nuoG or harbor an insertion mutation upstream of or within nuoG (Fig. 15A, lanes 5-9;
Fig. 15B, lanes 4 and 5), but detected NuoG in all other strains (Fig. 15A, lanes 3, 4,
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Fig. 15. Immunoblot analysis using E. coli anti-complex I polyclonal antibody
following SDS-PAGE (7.5% polyacrylamide) and transfer to nitrocellulose.
Molecular weight markers are indicated on the right; the NuoG and NuoCD subunits are
identified on the left. (A) Analysis ofwhole-cell lysates prepared from wild-type or nuo
polar mutant cells. Lanes: 1, purified complex I; 2, purified complex I mixed with wildtype lysate (strain CP366); 3, wild-type (CP875); 4, wild-type (CP366); 5, nuoB::Km
(AJW844); 6, nuoB-C::Cm (AJW853); 7, nuoF::miniTnlOCm (AJW851); 8, ll(nuoF-L)1 (CP938); 9, nuoG::Tnl0-1 (CP910); 10, nuoH::Km (AJW845); 11, nuo/::Km
(AJW846); 12, nuoM::miniTnlOCm (AJW852); 13, nuoN::Km (AJW847). Cells were
grown with aeration in TB at 32 °C until cultures reached mid-exponential phase
(OD 610=0.35-0.4). 100 µg whole-cell lysate loaded in each lane. (B) Analysis ofwholecell lysates prepared from wild-type or nuoG mutant cells. Lanes: 1, purified complex I;
2, purified complex I mixed with wild-type whole-cell lysate (CP366); 3, wild-type
(CP366 ); 4, ll(nuoF-L)-1 (CP938); 5, nuoG::Tnl0-1 (CP910); 6, llnuoGJ (AJW931); 7,
nuoG2 (AJW1470). Cells were grown as in Panel A. 100 µg whole cell lysate loaded in
each lane.
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11-14; Fig. 15B, lane 3). Cells that carry the alleles llnuoGJ (AJW931 (Fig. 15B, lane 6)
and AJW1516 (data not shown)) or nuoG2 (AJW1470 (Fig. 15B, lane 7) and AJW1 517
(data not shown)) synthesized proteins that exhibited faster and slower mobility,

nuoG allele

length Predicted
(aa's) ft4 (kDa)

wild-type

909

100.3

~uoGl

838

93.2

nuoG2

939

103.5

NuoG subunit (N ➔ C-terminus)

I
I

Fig. 16. Putative NuoG peptides. Length and molecular mass (Mr) of translation
products from the wild-type and mutant nuoG alleles as predicted by PeptideSort (41).
The C-terminal region (CTR) of NuoG (gray-hatched). The deletion in llnuoG 1 shifts the
remainder of the altered NuoG C-terminus out-of-frame (dark gray). The duplication in
nuoG2 shifts the duplicated CTR (black-hatched) and the remainder of the altered NuoG
C-terminus (dark gray) out-of-frame.

respectively, compared to the wild-type NuoG. The apparent molecular mass of each
variant roughly corresponded to the predicted product of their respective alleles (42) (Fig.
16). In addition, the steady state level of the smaller variant produced by llnuoG1 cells
(Fig. 15B, lane 6) seemed to be significantly less than that of the full-length NuoG
protein produced by the wild-type strain CP366 (Fig. 15B, lane 3). In contrast, the
amount of NuoCD protein produced by both strains seemed to be roughly equivalent. On
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the basis of these observations, we conclude that the llnuoGJ and nuoG2 alleles result in
the synthesis of altered forms of the NuoG subunit. The NuoG subunit is subject to
proteolytic digestion in disrupted cells (33). Perhaps the truncated NuoG subunit
resulting from the llnuoG1 allele is less abundant as a result of even more rapid
proteolytic digestion.

Effect of nuo Mutations on nuo Promoter Activity

To examine the effect that nuo mutations exert upon nuo promoter activity, we
monitored p-galactosidase activity from a nuoPA '::lacZYA operon fusion. We
transformed cells carrying the wild-type nuo locus (strain CP875) or the mutant alleles
nuoB::Km (AJW844), ll(nuoF-L)-l (CP938), nuoG::TnlO-l (CP910), llnuoGJ
(AJW1516), nuoG2 (AJW1517), nuoH::Km (AJW845), nuol::Km (AJW846), nuoM::Km
(AJW852), nuoN::Km (AJW847), llnuoGJ nuoH::Km (AJW1582), llnuoGJ nuol::Km
(AJW1583), nuoG2 nuoH::Km (AJW1584), llnuoGJ nuoM::Cm (AJW1567), llnuoGJ
nuoN::Km (AJW1568), or nuoG2 nuoM::Cm (AJW1569) with pHF9, a multi-copy
plasmid that carries the nuoPA ': :lacZYA operon fusion (Fig. 17A) or with its parental
vector, pRS415. We grew the resultant transformants in TB at 32°C, harvested and lysed
them as the cultures reached mid-exponential phase (0D610=0.35-0.4), and measured their
p-galactosidase activity. The mean sp act±SEM of at least six independent experiments
was plotted (Fig. 17B). Wild-type cells transformed with the vector control pRS415
displayed little or no p-galactosidase activity (sp act of 0.02±0.01). Relative to pHF9
transformants of wild-type cells, those of the nonpolar mutants llnuoGJ and nuoG2
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exhibited reduced P-galactosidase activity (sp act of 10.3±0.76 vs. 4.83±1.06 and
1.04±0.06, respectively). In contrast, pHF9 transformants of the llnuoGJ nuoH::Km,

llnuoGJ nuol::Km, and nuoG2 nuoH::Km double mutant strains exhibited significantly
higher activities (sp act of 27.50±5.60, 27.11±2.55, and 30.00±1.49, respectively) than
did the respective llnuoGJ, nuoG2, or wild-type transformants. This increase in activity
cannot be due merely to the presence of the nuoH: :Km or nuol: :Km mutations only since
transformants of those single mutants exhibited activities similar to that of the wild-type
transformants (10.20±0.68 and 15.74±1.47, respectively). In fact, transformants of all the
single mutants tested (except for the llnuoGJ and nuoG2 mutants) displayed activities
similar to that of the wild-type transformants. The double mutants llnuoGJ nuoM::Cm,

llnuoGJ nuoN::Km, and nuoG2 nuoM::Cm transformed with pHF9 displayed activities
only slightly higher than wild-type transformants (16.40±1.56, 18.96±2.04, and
13.52±0.582, respectively). We do not know why there was a difference in the level of
activity between the llnuoGJ and nuoG2 transformants, importantly their activity is
lower than that for wild-type transformants. Moreover, an additional mutation
downstream of either the llnuoG 1 or nuoG2 mutation eliminated any significance
difference in those transformants' activities. On the basis of these data, we propose that
NuoG participates in the regulation of nuo transcription possibly in conjunction with
some other Nuo subunit(s).
Interestingly, nuoG::TnlO transformant exhibited levels of P-galactosidase
activity similar to the wild-type transformant whereas the llnuoGJ and nuoG2
transformants displayed lower levels. This difference between the nuoG mutants may be
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Fig. 17. Effect of nuo mutations on nuo promoter activity. (A) pHF9, a multi-copy
nuoPA '::lacZYA transcriptional (operon) reporter fusion. Designations as in Fig. 6
legend. (B) p-galactosidase activity assay. Cells were grown in TB at 32 °C to midexponential phase (OD 610=0.35-0.4), harvested, lysed by sonication, and centrifuged to
separate the cytoplasmic from the membrane fraction. The p-galactosidase activity of the
cytoplasmic fractions was quantified as U/mg protein where U= µmol ONP formed/min.
The figure is a representation of at least six independent experiments. wt (CP875);
nuoB::Km (AJW844); a(nuoF-L)-1 (CP938); nuoG::Tnl0-1 (CP910); nuoH::Km
(AJW845); nuol::Km (AJW846); nuoM::miniTnJOCm (AJW852); nuoN::Km (AJW847);
anuoGJ (AJW1516); nuoG2 (AJW1517); anuoGJ nuoH::Km (AJW1582); anuoGJ
nuol::Km (AJW1583); nuoG2 nuoH::Km (AJW1583); anuoGJ nuoM::Cm (AJW1567);
anuoGJ nuoN::Km (AJW1568); nuoG2 nuoM::Cm (AJW1569).
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attributed to the polarity of the mutations. In the nuoG::TnlO mutant, we saw that all
transcription downstream of the mutation is eliminated therefore, none of the genes

nuoG-N are expressed. However, transcription of downstream genes does not seem to be
affected in either the dnuoGJ or nuoG2 mutant. It is likely that the decrease in

P-

galactosidase activity in the dnuoGJ and nuoG2 transformants is due not to the presence
of the altered NuoG subunits, rather it is due to the presence of the downstream Nuo
subunits unable to properly assemble.

Effect of Overexpression of nuo Genes on nuo Promoter Activity
We observed a significant decrease in expression from the nuo promoter only in
the dnuoGJ and nuoG2 mutants transformed with pHF9 and observed a decrease in
expression when transcription of nuoH-N was abolished by an additional mutation in
either nuoH or nuol. From our dot blot analysis, we know that the dnuoGJ and nuoG2
mutants transcribe nuoH-N. We assume that the NuoH-N subunits are synthesized in
these strains. On the basis of these results, we propose that NuoH-N may affect nuo
expression by repressing promoter activity. We tested whether the overexpression of

nuoH-N could decrease expression from the nuo promoter. We transformed wild-type
(CP875) cells with pHF9 (Fig. 6) alone or in conjunction with the compatible vector
pBAD33 or with constructs derived from pBAD33 that contain the nuoH-N genes either
in the same orientation as the P 8 AD promoter, pHF78, or in the opposite orientation from
the P 8 AD promoter, pHF79 (Fig. 8). We plated these transformants on LB X-gal indicator
plates containing the appropriate antibiotic(s) and 0.05% arabinose (for P 8 AD induction).
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These plates were incubated at 32 °C ON at which time the colonies were examined for
their color. Blue color signified P-galactosidase activity expressed from pHF9, whereas
white color indicated a little or no P-galactosidase activity (78). We quantified the Pgalactosidase activity by performing an ONPG assay (described in Materials and
Experimental Methods) with transformants grown in TB at 32°C to mid-exponential

phase (OD610=0.35-0.4). The results of these experiments are presented in a table below.

TABLE 5. Effect of nuoH-N overexpression on nuo promoter activity
Wild-type (CP875) cells transformed with:
P-galactosidase
activity

nuoPA '::lacZYA

nuoPA '::lacZYA +
vector

nuoPA '::lacZYA +
nuoH-N

nuoPA '::lacZYA +
nuoN-H

Color on X-gal:

blue

blue

white

white

sp act (U/mg):

~10.0

ND

<0.001

<0.001

Based on the results we observed on the indicator plates, we conclude that the Pgalactosidase activity is decreased in cells transformed with constructs carrying the
nuoH-N genes in either orientation (pHF78 or pHF79). This decrease is not merely due

to the presence of the pBAD33 vector-backbone, since no decrease was observed in cells
transformed with the vector pBAD33 without any nuo insert. The results of the ONPG
assay demonstrate that the decrease in P-galactosidase activity is significant. The nuoHN genes are oriented opposite that of the P8 AD promoter in pHF79; their expression may

be driven by the araC gene, the cat gene, or perhaps by some internal nuo promoter.
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Evidence for an internal promoter between nuoG and nuoN in S. typhimurium has been
presented by Archer and Elliott (3).
These results, while inconclusive, are intriguing. We would need to determine
whether nuoH-N are in fact being expressed in each construct before concluding that it is
the overexpression of nuoH-N leads to the decrease in nuo promoter activity we observed.

Studies with nuo: :lacZ Protein Reporter Fusions

To examine whether NuoA affects the expression from the nuo promoter, we
constructed two nuo::lacZYA protein fusions, one that contained all of nuoA and one that
did not. These fusions, pHF13 (the short fusion) and pHF14 (the long fusion), are
depicted in Fig. 18A. pHF13 is analogous to the operon fusion, pHF9: it contains nuoP
and the proximal third of nuoA cloned into the protein fusion vector pRS414. pHF 14
contains a slightly larger insert: it includes nuoP, all of nuoA, and the proximal third of
nuoB cloned into pRS414. The main difference between the two protein fusions is the
presence of only a partial nuoA gene in pHF13 or the entire nuoA gene in pHF14. We
assume that NuoA is synthesized from pHF 14, but not from pHF 13, and therefore the
levels ofNuoA would be higher in cells transformed with pHF14 than in those
transformed with pHF13. We transformed wild-type cells (CP875) with each of the
protein fusions or their parental vector, pRS414. We grew the cells in TB at 37°C and
measured their P-galactosidase activity over a growth curve (Fig. 18B). Cells
transformed with pHF 13 display a higher level of p-galactosidase activity throughout the
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Fig. 18. Expression studies with protein fusions. (A) pHF13 and pHF14, multi-copy
nuo::lacZYA translational (protein) reporter fusions. pHF13 contains a 443-bp nuo insert
whereas pHF14 contains a 992-bp nuo insert. Designations as in Fig. 7. (B) Pgalactosidase activity assay. Wild-type (CP875) cells transformed with vector pRS414
(■), pHF13 (e), or pHF14 (•). Transformants were grown in TB at 32°C and samples
removed at the indicated time points. The cells were lysed by sonication and centrifuged
to separate the cytoplasmic from the membrane fraction. The P-galactosidase activity of
the cytoplasmic fractions was quantified as U/mg protein where U= µmol ONP
formed/min. The mean±SEM of six independent experiments is plotted.
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growth curve than do cells transformed with pHF14. These results suggest that the
overexpression of nuoA reduces expression from the nuo promoter. This data also
substantiates a role for Nuo subunits, in this case NuoA, in the regulation of nuo
expression.

The Impact of Sigma Factors on nuo Promoter Activity
Three reports by different research groups describe or make reference to the
presence of 0 70-dependent promoter elements, specifically the -10 and/or -35 sequences,
within the nuo promoter in both E.coli and S. typhimurium (3, 12, 114). We tested the
hypothesis that the nuo promoter is, in fact,

0

70

-dependent. We used the nuoPA '::lacZYA

operon fusion, pHF9 (Fig. 6 and 17A), to study the effect of the sigma factors

0

70

(the

"housekeeping" sigma factor), as (0 38 ; the stationary phase/oxidative stress sigma factor),
and 0 54 ( oN; nitrogen/formate metabolism sigma factor) on nuo promoter activity (Fig.
19).
We transformed the operon fusion, pHF9, into wild-type cells (Strain CP875) or
sigma factor mutants (rpoDTs, strain UQ285; rpoS::Km, AJW1015; or rpoN::Tnl0-1,
AJW1409) and grew the transformants in TB supplemented with the requisite antibiotics
at the temperatures indicated. We harvested the cells at the indicated times and
measured their p-galactosidase activity as described previously.
To determine whether the nuo promoter is

0

70

-dependent as had been reported

previously, we examined nuo expression in an RpoDTs strain. We measured the

P-
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galactosidase activity of rpoD(Ts) cells (strain AJW1337) transformed with pHF9.
Surprisingly, we observed only a slight decrease in the P-galactosidase activity exhibited
by transformants at the permissive temperature (33 °C; RpoD+) versus those at the
restrictive temperature (44 °C; RpoD-) (Fig. 19A).
To determine whether the nuo promoter is 0 8-dependent, we measured the Pgalactosidase activity of wild-type cells (CP875) and rpoS::Km cells (AJW1015)
transformed with pHF9. We observed only a slight decrease in P-galactosidase activity in
Rpos- transformants (AJW1015 pHF9) compared to Rpos+ transformants (CP875 pHF9;
Fig. 19B). A similar result was achieved in S. typhimurium, where a katF (rpoS)
mutation introduced into a strain harboring a single-copy nuo promoter fusion resulted in
a slight decrease in P-galactosidase activity (3).
To determine whether the nuo promoter is

0

54

-dependent, we measured the P-

galactosidase activity of wild-type cells (CP875) and rpoN::Tnl0-1 cells (AJW1409)
transformed with pHF9. RpoN- transformants displayed a significantly reduced level of
p-galactosidase activity relative to the RpoN+ transformants (Fig. 19C).
While these studies are not exhaustive, we conclude that i)
role, if any, in regulating the nuo promoter and ii)

0

or indirectly, to expression from the nuo promoter.

54

0 70

and 0 8 play a minor

contributes greatly, either directly
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Fig. 19. nuo promoter activity in various sigma factor mutants. p-galactosidase
activity assays performed on cells transformed with the multi-copy nuoPA '::lacZYA
operon fusion, pHF9 (refer to Fig. 6 and 17A). Transformants were grown in TB at
37°C, unless otherwise stated, and samples removed at the indicated time points. The
cells were lysed by sonication and centrifuged to separate the cytoplasmic from the
membrane fraction. The p-galactosidase activity of the cytoplasmic fractions was
quantified as U/mg protein, where U= µmol ONP formed/min. (A) rpoD(Ts) cells (strain
AJW1337) transformed with pHF9. Cells were initially grown at 33 °C (permissive
temperature), then the culture was split and one half was grown at 33 °C, the other at
44 °C (restrictive temperature). The arrow indicates the time point at which the cultures
were split. RpoD+ (33 °C; ■), RpoD- (44 °C; e). (B) RpoS+ (wild-type, CP875; ■) or
Rpos- (rpoS::Km mutant, AJW1015; e) cells transformed with pHF9. (C) RpoN+ (wildtype, CP875; ■) or RpoN- (rpoN::TnlO mutant, AJW1409; e) cells transformed with
pHF9.

75

A

35

ci
E

2.
~

25

tiftl

20

~

411

Ill

ftl
"C

"iii

.2
u

15

ftl

ii
'i"

10

ca.
5
0

4

Time (hours)

B

40

ci
E

----- .
~

35

2.
~

>
t;

30

ftl
411

Ill

ftl
"C

25

iii
.2u
ftl
ii

'i"

ca.
4

5

6

7

8

9

Time (hours)

C

~

ci

-E

2.

____.

~
>

J

=
ftl

:s:!

Ill

.2u
ftl

ii

'i"

■

ca.

•

0
0

----------~

______.
--e

~=--r--r--r--r-,-1·
4

5

6

Time (hours)

7

8

10

CHAPTERIV
DISCUSSION

Nuo Phenotypes

We performed a genetic analysis of nuo, the E. coli locus that encodes the proton
translocating NADH dehydrogenase, complex I. Examining physiological, biochemical,
and molecular properties of mutants defective in nine of the fourteen nuo genes, we
demonstrated that a mutation in any one of the nuo genes tested causes a complex I
deficiency as measured by the inability of the mutant cells to i) form a inner, aspartate
ring on chemotaxis swarm plates, ii) grow rapidly in TB beyond mid-exponential phase,
iii) use acetate effectively as a sole carbon source, iv) exhibit membrane-associated
(d)NADH-FeCN activity, and v) detect membrane-associated Fe-S centers. Since each

nuo mutant exhibited all five Nuo- phenotypes, we used the swarm assay as a simple and
reliable Nuo- screen. The mechanism for this phenotypic defect remains unclear.
However, the absence of the inner, aspartate ring on swarm plates may result from the
inability to respire aerobically: wild-type cells grown anaerobically in the presence or
absence of an electron acceptor also do not form the inner ring (McNamara and Wolfe,
unpublished observation).
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Transcriptional Analysis
All of the nuo insertion mutations tested (nuoB-C: :Cm, nuoF: :miniTnl OCm;
nuoG::Tnl0-1, nuoH::Km, nuol::Km, nuoM::miniTnlOCm, and nuoN::Km) prevented

transcription of downstream genes, as judged by RNA dot blot analyses, with the
exception of the nuoB: :Km mutation. However, since we verified the location of the
mutation genetically and the nuoB: :Km mutant cells did not seem to synthesize the
NuoCD or NuoG subunit, as demonstrated by immunoblot analysis, the apparent
incomplete polarity exhibited by this mutation may be artifactual.
l::,.nuoGJ and nuoG2 represent the first recessive, nonpolar mutations located

within a single nuo gene. The RNA dot blot analyses revealed that both deletion
mutations (l::,.(nuoF-L)-l and l::,.nuoGJ) and the duplication mutation (nuoG2) do not exert
polar effects upon the transcription of downstream genes and complementation analyses
demonstrated that both the l::,.nuoGJ and nuoG2 mutant alleles are recessive: strains that
carry both the wild-type nuoG allele and either of these mutant alleles on their
chromosomes formed inner rings on swarm plates and did not exhibit the TB growth
defect. Since these integrant strains exhibited wild-type behaviors, we conclude that the
two halves of the nuo locus can be expressed independently. Expression of the
downstream half of the locus in these strains may result either from a promoter located
within nuoG or the 3' end of nuoF or from a promoter located within the vector.
Evidence for an internal promoter between nuoG and nuoN in S. typhimurium has been
presented by Archer and Elliott (3).
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We could not identify individual, discrete nuo transcripts using northern blot
analysis. We believe that this lack of discrete transcript( s) did not occur because the total
RNA was degraded during preparation or during transfer: both rRNA bands were intact
and a discrete acsA transcript was identified. The signal we observed using the both nuo
probes, however, not a result of non-specific hybridization: we observed a signal when
RNA from !1(nuoF-L)-l cells was probed with nuoA DNA but not when probed with
nuoHDNA. Unfortunately, the nuo transcript(s) does not appear to be stable under the

conditions tested. Further analysis of nuo transcripts will require the use of alternative
techniques such as primer extension, RNase protection, or in vitro transcription.

Protein Analysis

This is the first report of immunoblot analysis of E. coli cell lysates with an anticomplex I antibody. By analyzing selected members of our mutant collection, we
demonstrated that antibody #2409 recognizes both the NuoCD and NuoG subunits. As
predicted, the !1nuoGJ and nuoG2 mutants synthesized smaller and larger variants of the
NuoG subunit, respectively. Since all fourteen genes appear to be transcribed by !1nuoGJ
and nuoG2 cells, these cells presumably synthesized wild-type versions of all the other
Nuo subunits. Therefore, we conclude that functional complex I requires NuoG.
Fe-S centers were detected in the cytoplasm of the nuoN mutant by EPR
spectroscopy. The detection of these centers in the cytoplasm instead of associated with
the membrane supports the hypothesis that NuoE, NuoF, and NuoG subunits can form the
peripheral NDF in the absence of the membrane fragment. Furthermore, Braun and
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colleagues (14) have recently shown that the NDF is properly assembled without the
membrane fragment as long as the NuoCD subunit of the connecting fragment is present.
We demonstrate here that the C-terminal defects caused by deletion or duplication of the
235-bp CTR prevent complex I from functioning properly. Perhaps the altered NuoG
subunits cannot properly incorporate into the NDF or, if incorporated, prevent the further
assembly of other subunits.

Expression Studies
On the basis of the following evidence, we hypothesize that NuoG and at least one
other downstream subunit affect nuo promoter activity. First, of all the mutants tested,
only those carrying the l!!.nuoGJ or the nuoG2 mutation exhibited promoter activity
markedly reduced from that exhibited by wild-type cells when transformed with the
multi-copy nuoPA '::lacZYA operon fusion. This effect was not observed in nuoG::TnlO
or nuoH: :Km transformants suggesting that it is not the lack a functional NuoG alone that
causes an inhibitory effect at the nuo promoter. Second, this inhibitory effect was
alleviated by the additional presence of the nuoH: :Km or nuol: :Km mutations. To a
lesser extent, this was also true of the nuoM: :Cm or nuoN: :Km mutations. The nuoG
double mutants that contain either the nuoH: :Km or nuol: :Km mutations exhibited a
significant increase in promoter activity compared to those nuoG double mutants that
contain either the nuoM: :Cm or nuoN: :Km mutations. This suggests that the repression
observed in our experiments is orchestrated by a Nuo subunit(s) downstream ofNuoH,
yet upstream of NuoM.
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The overexpression of nuoH-N experiments are still incomplete. Since we
observed the same effect on promoter activity in cells expressing nuoH-N in both
orientations, we cannot conclude whether the effect is specifically due to the expression
of those genes. First, the expression of nuoH-N from each construct would need to be
verified by transcriptional and/or translational analysis. Second, if nuoH-N is being
expressed, the origin of expression needs to be determined in the construct where the
genes are oriented opposite that of the P 8 AD promoter. Finally, the gene(s) responsible for
the effect would need to be determined through deletion and mutational analysis.
Our data also is consistent with the ability ofNuoA to exert influence on nuo
promoter activity: cells that overexpress nuoA exhibited a reduced level of promoter
activity relative to those that do not overexpress nuoA. Further support for this
hypothesis comes from primer extension data from the S. typhimurium promoter (3, 29).

E. coli cells transformed with a multi-copy plasmid containing both the S. typhimurium
nuo promoter and nuoA exhibited the same levels of primer extension products as did
those transformed with a control vector or untransformed S. typhimurium cells. These
data are consistent with a role for NuoA as a repressor of nuo expression.
The results of the preceding experiments indicate that some of the Nuo subunits
may serve dual roles: they can act as structural components that participate in the
enzymatic activities of complex I plus they can function in a regulatory capacity. A
membrane-associated protein in S. typhimurium, PutA, is such a bifunctional enzyme. It
both couples the oxidation of pro line to glutamate with the transfer of electrons directly
to the electron transport chain in the cytoplasmic membrane and acts as a transcriptional
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repressor that binds DNA to regulate the put operon in response to proline (85). The two
activities are mutually exclusive and are determined in part by the cellular location of
PutA (80).
Both the NuoA and NuoH subunits contain putative DNA-binding regulatory
domains, consistent with the hypothesis that each possesses regulatory activity. The
NuoA subunit contains a LysR-like, helix-tum-helix DNA-binding motiflocated at its Nterminus, consistent with other members of the LysR family (42, 97). The NuoH subunit
contains an AraC-like, helix-tum-helix DNA-binding motif appropriately located at its Cterminus (19, 42). The hypothesis that NuoA can act as a negative regulator is supported
empirically by the decrease in promoter activity in cells overexpressing nuoA. The
hypothesis that NuoH serves as a regulator is supported by the experiments in which the
overexpression of nuoH-N resulted in a decrease in nuo promoter activity.

Model for complex I Assembly
The fungus Neurospora crassa assembles complete mitochondrial complex I en
bloc from two independently assembled subcomplexes (25, 31, 34, 57, 81, 98, 100, 108).
The peripheral arm, comprised of only nuclear-encoded subunits, was shown to assemble
independently of the membrane arm (34); while the membrane arm, comprised of both
nuclear- and mitochondrial-encoded subunits, was shown to assemble independently of
the peripheral arm (98). Once both arms are made, they are assembled into a single
enzyme complex at the mitochondrial matrix. If the NuoG homo log in N. crassa
(Nuo78) is deleted, then only the membrane arm of complex I is detected, the peripheral
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arm is not (41, 54). Similar results have been achieved after deleting other N. crassa (25,
31, 57, 81, 100) or human (57) complex I subunits. If a subunit from one arm is mutated,
the other arm can still subassemble.
We hypothesize that E. coli complex I assembly also proceeds first by
constructing independently assembled subcomplexes (Fig. 20). However, since E. coli
harbors all of its nuo components in a single cellular compartment, it is logical that the
regulation of expression and assembly would differ somewhat from that of the
eukaryotes. This hypothesis is inferred from our mutant data. We did not detect any
complex I activity or subcomplex formation in any of our nuo mutants, with the
exception ofthe nuoNmutant, in which an NDF was detected.
The following evidence supports the hypothesis of en bloc assembly of E. coli
complex I: i) the conserved clustering of the nuo locus (38, 68), ii) the evolution of
complex I (38-40, 68), iii) the detection of the NDF in the nuoN mutant (10), and iv) the
observation that the NDF is properly assembled in the absence of the membrane fragment
when NuoCD of the connecting fragment is present (14). On the basis of this
information, we propose that the llnuoGJ and nuoG2 mutants cause the complex I defect
because the altered NuoG subunits that they synthesize cannot be assembled into the
NDF properly. This, in turn, prevents further assembly of other Nuo subunits. This
hypothesis is supported by the inability to detect any Fe-S centers, present in the
peripheral and connecting fragments, by EPR spectroscopy in the llnuoG1 mutant.
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►

II
Fig. 20. Model for complex I assembly. The NuoCD subunit of the connecting
fragment is necessary for the peripheral subunits NuoE, NuoF, and NuoG to form
the peripheral fragment (NDF). Once the NDF and NuoCD have assembled, the
remaining connecting fragment subunits (NuoB and Nuol) can assemble. Next,
the membrane fragment assembles. It is unclear whether the membrane fragment
assembles with the rest of the subassembled complex I as a block or one subunit at
a time.
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To address the hypothesis that the l:,,.nuoGJ and nuoG2 mutations result in altered
NuoG subunits that cannot assemble into an NDF, a system similar to that used by Braun
and colleagues (14) can be employed. They have already established a system whereby
they can demonstrate formation of the NDF independent of the membrane fragment when

nuoB-G are expressed from an expression vector. In their system, wild-type nuoB-G is
cloned into an expression vector. That same system could be used where nuoB-l:,,.nuoG1
or nuoB-nuoG2 are cloned into the vector instead. Then cells transformed with these
expression constructs can be evaluated for their ability to assemble an NDF.
Furthermore, non-polar mutations introduced into nuoB, nuoC, or nuoD in the expression
constructs could provide information concerning which of the connecting subunits are
necessary for the assembly process. In conjunction with these genetic experiments,
pulse-labeling and immunoprecipitation experiments similar to those employed by N.

crassa complex I researchers (34) can be performed to witness the formation ofNDF
assembly intermediates.

Model for the Regulation of nuo Expression
Perhaps throughout its evolution, the nuo locus retained its precursors' regulatory
components to coordinate regulation of all its components, ensuring proper expression
and assembly of a complete and functional complex I. On the basis of our findings, we
hypothesize that E. coli cells can sense whether all of the Nuo subunits have been
synthesized and assembled, utilizing some form of feedback mechanism to regulate the
expression of nuo (Fig. 21 ). This mechanism would allow the cell to shut-down
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Fig. 21. Model for the feedback mechanism of regulation of nuo expression. The
llnuoG 1 mutant synthesizes a shortened, defective form of the NuoG subunit. This
altered NuoG subunit is unable to assemble as part of the NDF and therefore into the
complete complex I. Consequently, the connecting and membrane fragments are also
unable to assemble into the complete complex I. As a result, either the membrane
fragment and/or the subunits that constitute the membrane fragment are in excess in the
cytoplasm and are able to repress transcription from the nuo promoter. Thus, the Nuo
subunits participate in the regulation of nuo expression. This mechanism would allow
the cell to shut down expression of nuo when a functional complex I can not be made.
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expression of nuo when a functional complex I could not be made. Feedback
mechanisms are used by a number of other large protein complexes in E. coli, e.g. the
flagellar apparatus (70) and ribosomes (84, 121) to coordinately regulate their expression
and assembly.
The data that supports our hypothesis for feedback regulation of E. coli complex I
is as follows. First, the llnuoGJ and nuoG2 mutants do not make a functional complex I.
Second, these mutants synthesize defective forms of the NuoG subunit but, presumably,
synthesize all other Nuo subunits. Third, activity from the nuo promoter is reduced i) in
the llnuoGJ and nuoG2 mutants, ii) in cells that overexpress nuoA, and iii) in cells that
overexpress nuoH-N. These data may reflect separate, unrelated aspects of regulation;
alternatively, these data may provide insight into the overall regulatory network. Finally,
the reduced promoter activity observed in the llnuoGJ and nuoG2 mutants is repressed
by the absence ofNuoH-N. As stated above, we hypothesize that the altered NuoG
subunits cannot properly incorporate into the NDF. Then, in tum, the NDF would not be
available, so some or all of the components of the membrane fragment cannot associate
with the connecting fragment. This would cause the membrane subunits or the membrane
fragment to be in excess in the cytoplasm. Perhaps NuoA, NuoH, or a complete
subassembled membrane fragment could reduce expression of nuo by inhibiting
transcription at the nuo promoter.
The feedback regulation model we present concerning Nuo subunits affecting nuo
regulation arose from our studies with multi-copy operon and protein fusions. To
strengthen the physiological relevance of our results, it would be necessary to move to
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single-copy fusion studies. For example, we could further address the impact ofNuoA on
the nuo promoter by using a single-copy nuoP: :lacZYA operon fusion in conjunction with
an inducible expression construct expressing nuoA. IfNuoA does act as a repressor, then
we would expect to observe a reduction in promoter activity from the single-copy fusion
when nuoA expression is induced. Additionally, our model implies that one or more Nuo
subunits interact directly with the nuo promoter. There are a number of experimental
approaches that can be used to determine whether Nuo subunits bind the promoter. First,
the subunits of interest (for instance NuoG, NuoA, and NuoH) need to be synthesized and
purified. Then a variety of in vitro molecular techniques, such as gel shift analysis and
DNase I footprinting studies, can be employed to determine whether those subunits do, in
fact, bind to the nuo promoter and, more specifically, where that binding occurs on the
DNA. Using antibodies directed against those subunits, the specificity of binding can be
addressed.

Sigma Factor Regulation
A great deal of information has been attained concerning external regulators of
nuo. Researchers have demonstrated a role for both electron acceptors and electron
donors (12, 106) as well as global transcriptional regulators (12) in the regulation of nuo
expression. These studies provide insight into the environmental stimuli that affect nuo
expression. However, studies concerning which sigma factor(s) is responsible for nuo
expression have not been performed. Here, we present the first data concerning that
topic.
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We measured the ~-galactosidase activity in three mutants transformed with the

nuoPA '::lacZ operon fusion, each defective in one of three (69) E. coli sigma factors,

0

70

,

as, and 0 54 • We observed that ~-galactosidase activity was significantly decreased only in
cells defective for

0 54

(RpoN) but not for either 0 70 (RpoD) or as (RpoS). Contrary to

earlier speculation (3, 12, 114), these findings suggest that the major sigma factor of
exponential growth,

0

70

,

is not likely to be the major sigma factor controlling nuo

expression. Furthermore, according to our results, as, the major sigma factor during
stationary phase and the response to oxidative stress, also does not appear to be the major
sigma factor contributing to nuo expression. Instead, our results are consistent with 0 54 ,
the sigma factor responsible for nitrate and formate metabolism and anaerobic gene
expression, serving as the major sigma factor regulating nuo expression. While the -10/35

0 70-

binding consensus sequences in any one promoter is not highly conserved (45),

0 54-dependent

promoters conform to a precise consensus sequence TGGCAC-N5-

TTGCa/t located between -26 and -11 (76, 79). Surprisingly, we did not find this
consensus sequence anywhere within the nuo promoter. This suggests that 0 54 may i)
bind to some region of the promoter other than the known consensus sequence or ii) that

a 54 may work through an intermediate to regulate nuo expression, perhaps in conjunction
with another sigma factor(s). The most likely candidates are still

0

70

and as. One

hypothesis is that both 0 70 and as initiate transcription from the nuo promoter, but only in
the presence of some factor, factor X, expressed by a54 • If either 0 70 or as are absent, the
system does not get shut-down. However, if 0 54 is absent, then factor X cannot be
synthesized and neither 0 70 nor as can function.
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It is clear from our data that the role of sigma factors in the regulation of nuo
expression should be analyzed further. There are no studies addressing the role of sigma
factors in the regulation of any of the components of the respiratory chains (4 7). Our
results establish a role, direct or indirect, for

0

54

in the expression of nuo yet do not

completely rule out a role for either 0 70 or as. It is necessary to determine which of the
sigma factors bind the nuo promoter. DNasel footprinting and gel shift analyses have
proven to be reliable techniques for addressing this question (15, 49). To further define
the sigma factor/promoter interactions, in vitro transcription with reconstituted
holoenzyme also can be employed (105). Of course, it is possible that the

0

54

effect we

observed is indirect. Then, it would be necessary to identify what intermediate(s) through
which 0 54 functions. This might be accomplished using an E. coli library in conjunction
with the nuoPA '::/acZYA operon fusion to identify genes that affect nuo transcription
through 0 54 .

Long-term Goal
Thinking further into the future, a long-term goal may be to address how the
mechanism of nuo regulation works in concert with that of other respiratory chain
elements to balance a cell's redox state and to maximize its energy production. We
already understand to some degree, the environmental factors that regulate expression of
the respiratory chain enzymes. A more in depth examination of the coordinated
mechanisms will provide a great deal of insight into how energy metabolism is regulated
in the cell.

REFERENCES
1.
Alves, P. C. and A. Videira. 1994. Disruption of the gene coding for the 21.3kDa subunit of the peripheral arm of complex I from Neurospora crassa. The Journal of
Biological Chemistry 269:7777-7784.
Anraku, Y. and R. B. Gennis. 1987. The aerobic respiratory chain of
2.
Escherichia coli. Trends in Biochemical Sciences 12:262-266.

3.
Archer, C. D. and T. Elliott. 1995. Transcriptional control of the nuo operon
which encodes the energy conserving NADH dehydrogenase of Salmonella typhimurium.
Journal of Bacteriology 177:2335-2342.
Archer, C. D., X. Wang and T. Elliott. 1993. Mutants defective in the energy4.
conserving NADH dehydrogenase of Salmonella typhimurium identified by a decrease in
energy-dependent proteolysis after carbon starvation. Proceedings of the National
Academy of Sciences, USA 90:9877-9881.
Azvedo, J.E. and A. Videira. 1994. Characterization of a membrane fragment of
5.
respiratory chain complex I from Neurospora crassa. Insights on the topology of the
ubiquinone-binding sites. International Journal ofBiochemistry 26:505-510.

6.

Barrow, P.A. 1996. Personal communication.

Bauer, C. E. and T. H. Bird. 1996. Regulatory circuits controlling
7.
photosynthesis gene expression. Cell 85:5-8.

8.
Becker, S., G. Holighaus, T. Gabrielczyk and G. Unden. 1996. 0 2 as the
regulatory signal for FNR-dependent gene regulation in Escherichia coli. Journal of
Bacteriology 178:4515-4521.

9.
Bentlage, H., R. de Coo, H. ter Laak, R. Sengers, F. Trijbels, W. Ruitenbeek,
W. Scholte, K. Pfeiffer, S. Gencic, G. von Jagow and H. Schaegger. 1995. Human
diseases with defects in oxidative phosphorylation. European Journal of Biochemistry
227:909-915.
10.

Berger, A., V. Spehr and T. Friedrich. 1997. Manuscript in preparation.

90

91
11.
Bohm, R., M. Sauter and A. Bock. 1990. Nucleotide sequence and expression of
an operon in Escherichia coli coding for formate hydrogenylase components. Molecular
Microbiology 4:231-243.
·
Bongaerts, J., S. Zoske, U. Weidner and G. Unden. 1995. Transcriptional
12.
regulation of the proton translocating NADH dehydrogenase genes (nuoA-nuoN) of
Escherichia coli by electron acceptors, electron donors, and gene regulators. Molecular
Microbiology 16:521-534.

13.
Bowling, A. C. and M. Flint Beal. 1995. Minireview: Bioenergetic and oxidative
stress in neurodegenerative diseases. Life Sciences 56: 1151-1171.
14.
Braun, M., S. Bungert and T. Friedrich. 1997. Characterization of the
overproduced NADH dehydrogenase fragment of the NADH:ubiquinone oxidoreductase
(complex I) from Escherichia coli. Biochemistry In press:
15.
Buck, M. and W. Cannon. 1992. Specific binding of the transcription factor
sigma-54 to promoter DNA. Nature 358:422-424.
Calhoun, M. and R. B. Gennis. 1993. Demonstration of separate genetic loci
16.
encoding distinct membrane-bound respiratory NADH dehydrogenases in Escherichia
coli. Journal of Bacteriology 175:3013-3019.

17.
Casadaban, M. J. 1976. Transposition and fusion of the lac genes to selected
promoters in Escherichia coli using bacteriophage Lambda and Mu. Journal of Molecular
Biology 104:541-555.
18.
Casjens, S. and R. Hendrix. 1974. Comments on the arrangement of the
morphogenetic genes of bacteriophage lambda. Journal of Molecular Biology 90:20-23.
Cass, L. G. and G. Wilcox. 1988. Novel activation of araC expression and a
19.
DNA site required for araC autoregulation in Escherichia coli Bir. Journal of
Bacteriology 170:4174-4180.
Clark, M.A., L. Baumann and P. Baumann. 1997. Buchnera aphidicola
20.
(endosymbiont of aphids) contains nuoC(D) genes that encode subunits ofNADH
dehydrogenase. Current Microbiology 35:122-123.
Cortopassi, G. and E. Wang. 1995. Modeling the effects of age-related mtDNA
21.
mutation accumulation; complex I deficiency, superoxide and cell death. Biochimica et
Biophysica Acta 1271:171-176.

92
22.
Couceyro, P., M. Shoaib, M. McCoy, S. R. Goldberg and M. J. Kuhar. 1997.
Cocaine self-administration alters brain NADH dehydrogenase mRNA levels.
Neuroreport 8:2437-2441.
23.
Dancey, G. F., A. E. Levine and B. M. Shapiro. 1976. The NADH
dehydrogenase of the respiratory chain of Escherichia coli: properties of the membranebound enzyme, its solubilization, and purification to near homogeneity. Journal of
Biological Chemistry 251:5911-5920.
24.
Dancey, G. F. and B. M. Shapiro. 1976. The NADH dehydrogenase of the
respiratory chain of Escherichia coli: kinetics of the purified enzyme and the effects of
antibodies elicited against it on membrane-bound and free enzyme. Journal of Biological
Chemistry 251:5921-5928.
25.
Duarte, M., R. Sousa and A. Videira. 1995. Inactivation of genes encoding
subunits of the peripheral and membrane arms of Neurospora mitochondrial complex I
and effects on enzyme assembly. Genetics 139:1211-1221.
26.
Dupuis, A. 1992. Identification of two genes of Rhodobacter capsulatus coding
for proteins homologous to the ND 1 and 23 kDa subunits of the mitochondrial complex I.
FEBS Letters 301:215-218.
27.
Dupuis, A., A. Peinnequin, M. Chevallet, J. Lunardi, E. Darrouzet, B.
Pierrard, V. Procaccio and J. Issartel. 1995. Identification of five Rhodobacter
capsu/atus genes encoding the equivalent of ND subunits of the mitochondrial NADHubiquinone oxidoreductase. Gene 167:99-104.
28.
Dupuis, A., A. Peinnequin, E. Darrouzet and J. Lunardi. 1997. Genetic
disruption of the respiratory NADH-ubiquinone reductase of Rhodobacter capsulatus
leads to an unexpected photosynthesis-negative phenotype. FEMS Microbiology Letters
148:107-114.
29.

Elliott, T. 1995. Personal communication.

30.
Fearnley, I. M. and J.E. Walker. 1992. Conservation of sequences of subunits
of mitochondrial complex I and their relationships with other proteins. Biochimica et
Biophysica Acta 1140:105-134.
31.
Fecke, W., V. Sled, T. Ohnishi and H. Weiss. 1994. Disruption of the gene
encoding the NADH-binding subunit ofNADH:ubiquinone oxidoreductase in
Neurospora crassa: formation of a partially assembled enzyme without FMN and the
iron-sulphur cluster N-3. European Journal of Biochemistry 220:551-558.

93
32.
Ferrari, E. and J. A. Hoch. 1983. A single copy, transducible system for
complementation and dominance analysis in Bacillus subtilis. Molecular and General
Genetics 189:321-325.
·
33.

Friedrich, T. 1997. Personal communication.

34.
Friedrich, T., G. Hofbaus, W. Ise, U. Nehls, B. Schmitz and H. Weiss. 1989. A
small isoform of NADH:ubiquinone oxidoreductase (complex I) without mitochondrially
encoded subunits is made in chloramphenicol-treated Neurospora crassa. European
Journal of Biochemistry 180:173-180.

Friedrich, T., K. Steinmuller and H. Weiss. 1995. The proton-pumping
35.
respiratory complex I of bacteria and mitochondria and its homologue in chloroplasts.
FEBS Letters 367:107-111.
36.
Friedrich, T., M. Strohdeicher, G. Hofbaus, D. Preis, H. H. Sahm and H.
Weiss. 1990. The same domain motif for ubiquinone reduction in mitochondrial or
chloroplast NADH dehydrogenase and bacterial glucose dehydrogenase. FEBS Letters
265:37-40.

37.
Friedrich, T ., P. van Heek, H. Leif, T. Ohnishi, E. Forche, B. Kunze, R.
Jansen, W. Trowitzsch-Kienast, G. Hofle, H. Reichenbach and H. Weiss. 1994. Two
binding sites of inhibitors in NADH:ubiquinone oxidoreductase (complex I). European
Journal of Biochemistry 219:691-698.
Friedrich, T., U. Weidner, U. Nehls, W. Fecke, R. Schneider and H. Weiss.
38.
1993. Attempts to define distinct parts ofNADH:ubiquinone oxidoreductase (complex I).
Journal ofBioenergetics and Biomembranes 25:331-337.
39.
Friedrich, T. and H. Weiss. 1996. Origin and evolution of the proton-pumping
NADH:ubiquinone oxidoreductase (complex I). p. 205-220. In H. Baltscheffsky (ed.)
Origin and Evolution of Biological Energy Conversion. VCH Publishers, New York,
New York.
40.
Friedrich, T. and H. Weiss. 1997. Modular evolution of the respiratory
NADH:ubiquinone oxidoreductase and the origin of its modules. Journal of Theoretical
Biology 187:529-541.
41.

Friedrich, T. and H. Weiss 1997. Personal communication.

Genetics Computer Group, Inc. 1994. Wisconsin Package, version 8.1.
42.
Madison, WI.

94
43.

Gennis, R. 1995. Personal communication.

44.
Green, J. and J. R. Guest. 1994. Regulation of transcription at the ndh promoter
of Escherichia coli by FNR and novel factors. Molecular Microbiology 12:433-444.
45.
Gross, C. A., M. Lonetto and R. Losick. 1992. Bacterial sigma factors. p. 129176. In S. L. McKnight and K. R. Yamamoto (ed.) Transcriptional Regulation. Cold
Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
46.
Guenebaut, V., A. Schlitt, K. Leonard, H. Weiss and T. Friedrich. 1997.
Consistent structure between bacterial and mitochondrial NADH:ubiquninone
oxidoreductase (complex I). Journal of Molecular Biology. Submitted for publication.
4 7.

Gunsalus, R. 1997. Personal communication.

48.
Gunsalus, R. P. 1992. Control of electron flow in Escherichia coli: coordinated
transcription ofrespiratory pathway genes. Journal of Bacteriology 174:7069-7074.
49.
Guo, Y. and J. D. Grana. 1997. DNA-binding determinants of sigma 54 as
deduced from libraries of mutations. Journal ofBacteriology 179:1239-1245.
50.
Gutterson, N. I. and D. E. Koshland. 1983. Replacement and amplification of
bacterial genes with sequences altered in vitro. Proceedings of the National Academy of
Science, USA 80:4894-4898.
51.
Guzman, L., D. Belin, M. J. Carson and J. Beckwith. 1995. Tight regulation,
modulation, and high-level expression by vectors containing arabinose P 8 AD promoter.
Journal ofBacteriology 177:4121-4130.
52.
Hamilton, C. M., M. Aldea, B. K. Washburn, P. Babitzke and S. R. Kushner.
1989. New method for generating deletions and gene replacements in Escherichia coli.
Journal of Bacteriology 171 :461 7-4622.
53.
Hanahan, D. 1983. Studies on transformation of Escherichia coli with plasmids.
Journal of Molecular Biology 166:557-580.
54.
Harkness, T. A. A., R. A. Rothery, J. H. Weiner, S. Werner, J.E. Azvevedo,
A. Vidieira and F. E. Nargang. 1995. Disruption of the gene encoding the 78-kilodalton
subunit of the peripheral arm of complex I in Neurospora crassa by repeat induced point
mutation. Current Genetics 27:339-350.
55.
Harlow, E. and D. Lane. 1988. Immunoassays. p. 563-566. In Antibodies: A
laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.

95
56.

Hewlett-Packard, Corp. 1991. DeskScan II. Palo Alto, CA.

57.
Hofhaus, G. and G. Attardi. 1993. Lack of assembly of mitochondrial DNAencoded subunits of respiratory NADH dehydrogenase and loss of enzyme activity in a
human cell mutant lacking the mitochondrial ND4 gene product. The EMBO Journal
12:3043-3048.
58.
Hofhaus, G., H. Weiss and K. Leonard. 1991. Electron microscopic analysis of
the peripheral and membrane parts of mitochondrial NADH dehydrogenase (complex I).
Journal of Molecular Biology 221:1027-1043.
59.
Hughes, K. T., K. L. Gillen, M. J. Semon and J.E. Karlinsey. 1993. Sensing
structural intermediates in bacterial flagellar assembly by export of a negative regulator.
Science 262:1277-1280.
60.
Iuchi, S. and E. C. C. Lin. 1993. Adaptation of Escherichia coli to redox
environments by gene expression. Molecular Microbiology 9:9-15.
61.
Jaworowski, A., H. D. Campbell, M. I. Poulis and I. G. Young. 1981. Genetic
identification and purification of the respiratory NADH dehydrogenase of Escherichia
coli. Biochemistry 20:2041-2047.
62.
Jaworowski, A., G. Mayo, D. C. Shaw and H. D. Campbell. 1981.
Characterization of the respiratory NADH dehydrogenase of Escherichia coli and
reconstitution of ndh mutant membrane vesicles. Biochemistry 20:3621-3628.
63.
Jeffers, C. E. and W.R. Widger. 1997. Clues toward the proton translocation
mechanism and evolution of complex I revealed through sequence analysis of
hydrophobic subunits. FASEB Journal 11:A1077.
64.
Komen, R., D. Zannoni, W. J. Ingledew and K. Schmidt. 1991. The electron
transport system of Alcaligenes eutrophus Hl6. Archives of Microbiology 155:382-390.
65.
Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the
head of bacteriophage T4. Nature (London) 227:680-685.
66.
Laval-Favre, K., B. Letovet-Pawalak, T. Friedrich, J. Alexandre and J.
Guespin-Michel. 1997. A gene involved in both protein secretion during growth and
starvation-induced development encodes a subunit of the NADH:ubiquinone
oxidoreductase in Myxococcus xanthus. Molecular Microbiology 23: 1043-1052.

96
67.
Leif, H., V. D. Sled, T. Ohnishi, H. Weiss and T. Friedrich. 1995. Isolation and
characterization of the proton-translocating NADH:ubiquinone oxidoreductase from
Escherichia coli. European Journal of Biochemistry 230:538-548.
·
68.
Leif, H., U. Weidner, A. Berger, V. Spehr, M. Braun, P. van Heek, T.
Friedrich, T. Ohnishi and H. Weiss. 1993. Escherichia coli NADH dehydrogenase I, a
minimal form of the mitochondrial complex I. Biochemical Society Transactions 21:9981001.
69.
Lonetto, M.A. and C. A. Gross. 1996. Nomenclature of sigma factors from
Escherichia coli and Salmonella typhimurium and relationships to sigma factors from
other organisms. p. 821. In F. Neidhardt (ed.) Escherichia coli and Salmonella Cellular
and Molecular Biology, vol. 2. ASM Press, Washington, DC.
Losick, R. and L. Shapiro. 1993. Checkpoints that couple gene expression to
70.
morphogenesis. Science 262:1227-1228.

71.
Macnab, R. M. 1992. Genetics and biogenesis ofbacterial flagella. Annual
Review of Genetics 26:131-158.
Matsushita, K. and H. R. Kaback. 1986. D-lactate oxidation and generation of
72.
the proton electrochemical gradient in membrane vesicles from Escherichia coli GRl 9N
and in proteoliposomes reconstituted with purified D-lactate dehydrogenase and
cytochrome o oxidase. Biochemistry 25:2321-2327.

73.
Matsushita, K., T. Ohnishi and H. R. Kaback. 1987. NADH-ubiquinone
oxidoreductases of the Escherichia coli aerobic respiratory chain. Biochemistry 26:77327737.
Matsushita, K., E. Shinagawa, 0. Adachi and M. Ameyama. 1989. Reactivity
74.
with ubiquinone of quinoprotein D-glucose dehydrogenase from Gluconobacter
suboxydans. Journal of Biochemistry 105:633-637.
Meissler, S., R. Langhammer and A. Quinones. 1997. A Tn5 insertion in the
75.
nuo operon of Escherichia coli causes an enhanced dnaN expression and an increase in
the frequency of frameshift and deletion mutations. PF107, p. 1-120. In Abstracts of
Sonderausgabe zur Friihjahrstagung of the Vereinigung fiir Allegemeine und Angewandte
Mikrobiologie 1997. Vereinigung fiir Allegemeine und Angewandte Mikrobiologie
Hamburg, Germany.

76.
Merrick, M. J. 1993. In a class of its own- the RNA polymerase sigma factor
(oN). Molecular Microbiology 10:903-909.

0

54

97
77.

Microsoft, Corp. 1994. PowerPoint, version 4.0. Seattle, WA.

78.
Miller, J. H. 1972. Experiments in Molecular Genetics. Cold Spring Harbor·
Laboratories, Cold Spring Harbor, NY.
79.
Morett, E. and M. Buck. 1989. In vivo studies on the interaction of RNA
polymerase-a54 with the Klebsiella pneumoniae and Rhizobium meliloti nifH promoters.
Journal of Molecular Biology 210:65-77.
80.
Muro-Pastor, A. M., P. Ostrovsky and S. Maloy. 1997. Regulation of gene
expression by repressor localization: biochemical evidence that membrane and DNA
binding by the PutA protein are mutually exclusive. Journal of Bacteriology 179:27882791.
81.
Nehls, U., T. Friedrich, A. Schmiede, T. Ohnishi and H. Weiss. 1992.
Characterization of assembly intermediates of NADH:ubiquinone oxidoreductase
(complex I) accumulated in Neurospora mitochondria by gene disruption. Journal of
Molecular Biology 227:1032-1042.
82.
Neijessel, 0. M. and M. J. Teixeira de Mattos. 1994. The energetics of bacterial
growth: a reassessment. Molecular Microbiology 13:179-182.
83.
Neumann, B., A. Pospiech and H. U. Schairer. 1992. Rapid isolation of
genomic DNA from gram-negative bacteria. Trends in Genetics 8:332-333.
84.
Nomura, M., R. Gourse and G. Baughman. 1984. Regulation of the synthesis
of ribosomes and ribosomal components. Annual Review of Biochemistry 53:75-117.
85.
Ostrovsky de Spicer, P. and S. Maloy. 1993. PutA protein, a membraneassociated flavin dehydrogenase, acts as a redox-dependent transcriptional regulator.
Proceedings of the National Academy of Science, USA 90:4295-4298.
86.
Ozawa, T. 1997. Genetic and functional changes in mitochondria associated with
aging. Physiological Reviews 177:425-464.
87.
Park, C. P. and G. L. Hazelbauer. 1986. Mutations specifically affecting ligand
interaction of the TRG chemosensory transducer. Journal of Bacteriology 167:101-109.
88.
Perego, M. 1993. Integrational vectors for genetic manipulation in Bacillus
subtilis. p. 615-624. In A. L. Sonenshein, J. A. Hoch and R. Losick (ed.) Bacillus subtilis
and other Gram-positive bacteria. Biochemistry, physiology, and molecular genetics.
ASM Press, Washington DC.

98
89.
Pich, M. M., C. Bovina, G. Formiggini, G. G. Cometti, A. Ghelli, G. P.
Castelli, M. L. Genova, M. Marchetti, S. Semeraro and G. Lenaz. 1996. Inhibitor
sensitivity of respiratory complex I in human platelets: a possible biomarker of ageing.
FEBS Letters 780: 176-178.
90.
Pilkington, S. J., M. Skehel, R. B. Gennis and J.E. Walker. 1991.
Relationship between mitochondrial NADH-ubiquinone reductase and a bacterial NADreducing hydrogenase. Biochemistry 30:2166-2175.
91.
PriiP B. M., J.M. Nelms, C. Park and A. J. Wolfe. 1994. Mutations in
NADH:ubiquinone oxidoreductase of Escherichia coli affect growth on mixed amino
acids. Journal of Bacteriology 176:2143-2150.
92.
Reanney, D. C. and H. W. Ackermann. 1985. Comparitive biology and
evolution of bacteriophages. Advances in Virus Research 27:205-280.
93.
Reizer, A., G. M. Pao and M. H. Saier. 1991. Evolutionary relationships among
permease proteins of the bacterial phosphoenolpyruvate: sugar phosphotransferase
system. Constitution of phylogenetic trees and possible relatedness to proteins of
eukaryotic mitochondria. Journal ofMolecular Evolution 33:179-193.
94.
Saiki, R. K. 1990. Amplification of genomic DNA. p. 13-20. In M.A. Innis, D.
H. Gelfand, J. J. Sninsky and T. J. White (ed.) PCR Protocols: A Guide to Methods and
Applications. Academic Press, Inc., San Diego, CA.
95.
Sambrook, J.E., E. F. Fritsch and T. Maniatis. 1989. Molecular Cloning: A
laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
96.
Schapira, A.H. V. 1995. Oxidative stress in Parkinson's Disease.
Neuropathology and Applied Neurobiology 21:3-9.
97.
Schell, M.A. 1993. Molecular biology of the LysR family of transcriptional
regulators. Annual Review of Microbiology 47:597-626.
98.
Schmidt, M., T. Friedrich, J. Wallrath, T. Ohnishi and H. Weiss. 1992.
Accumulation of the preassembled membrane arm ofNADH:ubiquinone oxidoreductase
in mitochondria of manganese-limited grown Neurospora crassa. FEBS Letters 313:811.
99.
Schoffner, J.M. and D. Wallace. 1994. Oxidative phosphorylation diseases and
mitochondrial mutations: diagnosis and treatment. Annual Review of Nutrition 14:535568.

99
100. Schulte, U., W. Fecke, C. Krull, U. Nehls, A. Schmiede, R. Schneider, T.
Ohnishi and H. Weiss. 1994. In vivo dissection of the mitochondrial NADH:ubiquinone
oxidoreductase (complex I). Biochimica et Biophysica Acta 1187:121-124.
·
101. Silhavy, T. J., M. L. Berman and L. W. Enquist. 1984. Experiments with Gene
Fusions, 1st ed., Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
102. Simons, R. W., F. Houman and N. Kleckner. 1987. Improved single and
multicopy lac-based cloning vectors for protein and operon fusions. Gene 53:85-96.
103. Smith, P. K., R. J. Krohen, G. T. Hermansen, A. K. Mallia, F. H. Gartner, M.
D. Provenzano, E. K. Fujimoto, N. M. Goeke, B. J. Olsen and D. C. Klenk. 1985.
Measurement of protein using bicinchoninic acid. Analytical Biochemistry 150:76-85.
104. Spiro, S., R. E. Roberts and J. R. Guest. 1989. FNR-dependent repression of
the ndh gene of Escherichia coli and metal ion requirement for FNR-regulated gene
expression. Molecular Microbiology 3:601-608.
105. Tanaka, K., Y. Takayanagi, N. Fujita, A. Ishihama and H. Takahashi. 1993.
Heterogeneity of the principal o factor in Escherichia coli: the rpoS gene product 0 38 , is a
second principal o factor of RNA polymerase in stationary-phase Escherichia coli.
Proceedings of the National Academy of Sciences, USA 90:2511-3515.
106. Tran, Q. H., J. Bongaerts, D. Vlad and G. Unden. 1997. Requirement for the
proton-pumping NADH dehydrogenase I of Escherichia coli in respiration of NADH to
fumarate and its bioenergetic implications. European Journal of Biochemistry 244:155160.
107. Tran-Betcke, A., U. Warnecke, C. Bocker, C. Zaborosch and B. Friedrich.
1990. Cloning and nucleotide sequences of the genes for the subunits ofNAD-reducing
hydrogenase of Alcaligenes eutrophus Hl6. Journal of Bacteriology 172:2920-2929.
108. Tuschen, G., U. Sackmann, U. Nehls, H. Haiker, G. Buse and H. Weiss. 1990.
Assembly of NADH:ubiquinone reductase (complex I) in Neurospora mitochondria.
Independent pathways of nuclear-encoded and mitochondrially encoded subunits.
Molecular Biology 213:845-847.
109. Unden, G. and J. Bongaerts. 1997. Alternative respiratory pathways of
Escherichia coli: energetics and transcriptional regulation in response to electron
acceptors. Biochimica et Biophysica Acta 1320:217-234.
110.

Vik, S. 1997. Personal communication.

100
111. Walker, J.E. 1992. The NADH:ubiquinone oxidoreductase (complex I) of
respiratory chains. Quarterly Review of Biophysics 25:253-324.
112. Walker, J.E. and A. L. Cozens. 1986. Evolution of ATP synthase. Chemical
Scripta 26B:263-272.
113. Walker, J.E., M. Saraste and N. J. Gay. 1984. The unc operon: nucleotide
sequence, regulation, and structure of ATP synthase. Biochimica et Biophysica Acta
768: 164-200.
114. Weidner, U., S. Geier, A. Ptock, T. Friedrich, H. Leif and H. Weiss. 1993. The
gene locus of the proton-translocating NADH:ubiquinone oxidoreductase in Escherichia
coli. Journal of Molecular Microbiology 233:109-122.
115. Weidner, U., U. Nehls, R. Schneider, W. Fecke, H. Leif, A. Schmiede, T.
Friedrich, R. Zensen, U. Schulte, T. Ohnishi and H. Weiss. 1992. Molecular genetic
studies of complex I in Neurospora crassa, Aspergillus niger, and Escherichia coli.
Biochimica et Biophysica Acta 1101:177-180.
116. Weiss, H., T. Friedrich, G. Hotbaus and D. Preis. 1991. The respiratory chain
NADH dehydrogenase (complex I) of mitochondria. European Journal of Biochemistry
197:563-576.
117. Wolfe, A. J., M. P. Conley, T. J. Kramer and H. C. Berg. 1987. Reconstitution
of signaling in bacterial chemotaxis. Journal of Bacteriology 169:1878-1885.
118. Xu, X., A. Matsuno-Yagi and T. Yagi. 1993. DNA sequencing of the seven
remaining structural genes of the gene cluster encoding the energy-transducing NADHquinone oxidoreductase of Paracoccus denitrificans. Biochemistry 32:968-981.
119. Yagi, T., X. Xu and A. Matsuno-Yagi. 1992. The energy-transducing NADH
quinone oxidoreductase (NDH-1) of Paracoccus denitrificans. Biochimica et Biophysica
Acta 1101:181-184.
120. Yagi, T., T. Yano and A. Matsuno-Yagi. 1993. Characteristics of the energytransducing NADH-quinone oxidoreductase of Paracoccus denitrificans as revealed by
biochemical, biophysical, and molecular biological approaches. Journal of Bioenergetics
and Biomembranes 25:339-345.
121. Yamagishi, M. and M. Nomura. 1988. Effects of induction ofrRNA
overproduction on ribosomal protein synthesis and ribosome subunit assembly in
Escherichia coli. Journal of Bacteriology 170:5042-5050.

101
122. Yano, T., S.S. Chu, V. D. Sled, T. Ohnishi and T. Yagi. 1997. The protontranslocating NADH-quinone oxidoreductase (NDH-1) ofthermophilic bacterium
Thermus thermophilus HB-8. Journal of Biological Chemistry 272:4201-4211.
123. Yim, H. H., R. L. Brems and M. Villarejo. 1994. Molecular characterization of
the promoter of osmY, an rpoS-dependent promoter. Journal of Bacteriology 176:100107.
124. Young, I. G. and B. J. Wallace. 1976. Mutations affecting the reduced
nicotinamide adenine dinucleotide dehydrogenase complex of Escherichia coli.
Biochimica et Biophysica Acta 449:376-385.
125. Youngman, P. 1990. Use oftransposons and integrational vectors for
mutagenesis and construction of gene fusions in Bacillus species. p. 221-257. In C.R.
Harwood and S. M. Cutting (ed.) Molecular biological methods for Bacillus. John Wiley
and Sons, West Sussex, England.
126. Zambrano, M. M. and R. Kolter. 1993. Escherichia coli mutants lacking the
NADH dehydrogenase I have a competitive disadvantage in stationary phase. Journal of
Bacteriology 175:5642-5647.

VITA

The author, Holly J. Falk-Krzesinski, was born in Skokie, Illinois to Ileen and
Kenneth Falk. She received her secondary education at Maine Township High School
East in Park Ridge, Illinois where she graduated in 1988. She then attended the
University of Illinois at Chicago where she received a Bachelor of Liberal Arts and
Sciences degree with college honors in 1992. During this time, Ms. Falk-Krzesinski
pursued a Biological Sciences major and a minor in Chemistry as well as performed an
undergraduate research project in the laboratory of Dr. F. Marion Hulett.
During her studies at UIC, Ms. Falk-Krzesinski was employed by Abbott
Laboratories as a research intern in the Pharmaceutical Products Research and
Development Division under the guidance of Dr. Robert Simmer. She was involved in
the expression and purification of proteins with pharmaceutical potential.

In August 1992, Ms. Falk-Krzesinski began her graduate studies in the
Department of Microbiology and Immunology at Loyola University Chicago. The
following August, she married Mitch Krzesinski. One month later, she joined the
laboratory of Dr. Alan J. Wolfe. In Dr. Wolfe's laboratory, Ms. Falk-Krzesinski focused
her efforts on studying how Escherichia coli cells regulate the expression and assembly
of the respiratory chain enzyme, complex I.

102

103
Ms. Falk-Krzesinski was the recipient of a number of fellowships and travel
grants throughout her graduate career. These include the Association for Women in
Science Educational Foundation Amy Lutz Rechel Foundation Award in 1997, the
American Society of Microbiology/American Academy of Microbiology Raymond W.
Sarber Award in 1997, the Sigma Delta Epsilon/Graduate Women in Science Eloise
Gerry Research Fellowship in 1996, the Alpha Kappa Alpha Educational Advancement
Foundation Alice Thomas Motts Trust Merit Scholarship in 1996, and the Loyola
University Dissertation Fellowship in 1996.
Ms. Falk-Krzesinski has accepted a position as a Postdoctoral Research Associate
in the laboratory of Dr. Gail Hecht in the Department of Medicine, Section of Digestive
and Liver Disorders at the University of Illinois at Chicago. There she will investigate
the effects of enteropathogenic Escherichia coli on the host immune response at the
molecular level.

DISSERTATION APPROVAL SHEET

The dissertation submitted by Holly J. Falk-Krzesinski has been read and approved by the
following committee:
Alan J. Wolfe, Ph.D., Advisor
Associate Professor, Microbiology and Immunology
Loyola University Chicago
Adam Driks, Ph.D.
Assistant Professor, Microbiology and Immunology
Loyola University Chicago
David Hecht, M.D.
Associate Professor, Infectious Diseases
Loyola University Chicago
Robert Gennis, Ph.D.
Professor, Biochemistry
University of Illinois, Champaign-Urbana
F. Marion Hulett, Ph.D.
Professor, Laboratory for Molecular Biology
University of Illinois, Chicago
The final copies have been examined by the advisor of the dissertation and the signature
which appears below verifies the fact that any necessary changes have been incorporated
and that the dissertation is now given final approval by the committee with reference to
content and form.
The dissertation is, therefore, accepted in partial fulfillment of the requirements for the
degree of Doctor of Philosophy.

